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ABSTRACT
Inductively coupled plasmas (ICPs) efficiently excite and ionize metals and 
semi-metals allowing for their detection by atomic emission spectroscopy (AES) or 
mass spectrometry (MS). Nonmetal analytes are more difficult to detect due to their 
higher excitation and ionization energies. The sensitive detection of nonmetal 
analytes is becoming increasingly important in the pharmaceutical industry as new 
drug compounds and impurities containing nonmetals are being developed. These 
compounds are typically detected after they are separated by high performance liquid 
chromatography (HPLC). The research presented in this dissertation investigates the 
application of ultrasonic nebulization and membrane desolvation (USN-MD) with 
ICP-MS and ICP-AES as detectors for nonmetal analytes speciated by HPLC.
A study identified which HPLC mobile phases and buffers lead to sensitive 
determinations for a phosphorus-containing analyte with ICP-AES and ICP-MS 
detection. For ICP-AES detection, neither large signal enhancements nor 
degradations were observed for the buffers and mobile phase combinations tested. It 
was determined that gradient elution could be performed with USN-MD-ICP-AES 
detection. For ICP-MS detection, effects o f  these buffers were more significant. A  
large decrease in sensitivity was noted when the mobile phase included organic 
solvents. Isocratic elution conditions are suggested when USN-MD-ICP-MS 
detection is utilized.
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The addition o f supplemental gases to the nebulizer gas flow of an ICP-MS 
was also investigated. For oxygen addition, signal degradation was noted for sulfur-, 
phosphorus-, and chlorine-containing analytes. It was determined that 6 % oxygen in 
the nebulizer gas flow yielded efficient removal of carbon while not appreciably 
increasing detection limits. With nitrogen addition, a large increase in the 
background signal was found for phosphorus determinations. A decrease in 
sensitivity was found when determining sulfur. Helium addition did not produce 
significant deviations from standard argon ICP behavior, indicating that it is not being 
significantly ionized.
A final study utilized ICP-MS as a detector for the separation of several model 
analyte systems. It was found that significant band broadening occurred for several 
volatile analytes, reducing sensitivity and negatively affecting chromatographic 
figures of merit. However, nonvolatile analytes yielded sensitive determinations.
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CHAPTER 1
INDUCTIVELY COUPLED PLASMA ATOMIC SPECTROMETRY FOR 
PHARMACEUTICAL ANALYSIS
Introduction to Elemental Analysis and Common Atomization, Excitation, and
Ionization Sources
Elemental analysis is an essential field of analytical chemistry with the 
objective of identification and quantification of the constituent atoms of a sample.
The utility of such analyses is in their reliance on characteristic responses of the 
individual atoms within a molecule rather than the response of the entire molecule.
For example, the atomic emission spectrum of phosphorus is characteristically 
unchanged whether it is present as the insecticide diethyl parathion (C10H 14NO5PS) or 
the nucleophilic reagent triphenyl phosphine (P(C6Hs)3 ). A consistent atomic line 
emission signal at 253.5 nm will be evident for both compounds. Contrast this with an 
analytical technique such as infrared spectroscopy that measures the absorption of 
infrared radiation corresponding to rotational and vibrational energies between the 
covalently bonded atoms of a molecule. Figures 1 and 2 illustrate infrared spectra of 
diethyl parathion (C10H 14NO 5PS) and triphenyl phosphine (P(C6H5)3). While the
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Figure 1. Infrared spectrum of diethyl parathium (adapted from NIST Chemistry
WebBook1).
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Figure 2. Infrared spectrum of triphenyl phosphine (adapted from NIST Chemistry
WebBook ).
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spectra are substantially different and make qualitative identification 
straightforward, it is not difficult to imagine that a sample with several compounds 
would yield an over-lapping spectrum making sample analyses difficult, or even 
impossible. Reducing a molecule into constituent atoms for identification and 
quantification provides atomic spectrometric techniques with unique advantages 
compared to other analytical methods.
There are several atomic spectrometric techniques available to the analytical 
chemist. All require complete atomization of the analyte molecule to obtain a useful 
analytical signal. The most common of these techniques are atomic absorption, 
emission, fluorescence, and mass spectrometry. Whereas the production of the 
monitored species may differ from one technique to another, the conversion of the 
analyte molecule to analyte atoms requires comparable atomization steps.
Atomic absorption and fluorescence techniques typically utilize atmospheric 
pressure flames as an atomization source. These flames are composed of a fuel, such 
as acetylene, and an oxidant, such as air or nitrous oxide. The energy of the flames is 
utilized to break intramolecular bonds to produce free atoms that may be interrogated 
with incident light for absorption or fluorescence measurements. These flames can 
achieve temperatures in excess of 3000 K (Table 1) and yield high atomization 
efficiencies dependent on the fuel-oxidant type (Table 2 ) 2.
Atomic emission and mass spectrometry require atomization of the analyte 
molecule. Atom excitation is necessary for emission spectroscopy. Ionization is 
required for mass spectrometric analysis. Ideal sources for these
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Table 1. Temperatures for common chemical flames (adapted from Ingle, Crouch ). 
Fuel -  oxidant_______ Theoretical stoichiometric temperature (K)
C3 H8 -  air 2267
H2  -  air 2380
C2 H2  -  air 2540
H2 - O 2 3080
c 3 h 8 - o 2 3094
C2 H2 - N 2 O 3150
C2 H2  — O2 3342
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6Table 2. Atomization efficiency (Nm/Nt) of selected elements in an air-acetylene and 
N2 0 -acetylene flame. Nm is the total number density of free metal atoms and Nt is the 
total number density of metal-containing species. Some species efficiencies are 
relative to Cu for which Nm/Nt = 1.00 was assigned (adapted from Ingle, Crouch)2.
Element____________ CiH^-air flame_________ C2H2-N2O flame
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techniques should have the following characteristics: a high atomization efficiency, 
sufficient energy to excite or ionize analyte atoms, a chemical environment conducive 
to background signal minimization, sufficient energy to ionize or electronically excite 
the element of interest, robustness with a variety of experimental conditions, stability 
to maintain accuracy and reproducibility, capability for simultaneous multi-element 
analysis, and simple operation2. Potential sources for atomic emission include 
flames, inductively coupled plasmas (ICPs), microwave-induced plasmas (MIPs), and 
direct current plasmas (DCPs). Due to their superior ionization and excitation 
capabilities, plasmas are the preferred atom sources for atomic emission (AES) and 
atomic mass spectrometry (MS).
Direct current plasmas are typically used only for emission spectroscopy. 
DCPs typically consist of two or three electrodes that provide a direct current 
discharge to a stream of partially ionized gas. These plasmas can attain temperatures 
up to 6000 K . Argon gas is used to deliver the analyte as nebulized aerosol to the 
plasma where it is desolvated, atomized, and excited. The DCP provides an electron- 
rich environment lessening ionization interferences, is able to tolerate high solids in 
solution and organic solutions, and has power requirements less than 1 kilowatt. 
Disadvantages of the DCP include short residence time of the analyte within the 
plasma and a small optimum analytical zone cross-section for analyte detection2.
Microwave induced plasmas typically utilize a focused microwave field to 
maintain the discharge. The plasma is contained in a quartz torch as shown in Figure
3. MIPs have been formed with argon, helium, and nitrogen gases, providing 
microwave powers from 25 to 3000 watts ' .  Microwave plasmas provide for gas
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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temperatures up to 3000 K and excitation temperatures up to 5000 K. Due to the 
lower temperatures compared to DCPs atomization efficiency, solvent tolerance, and 
interference effects are more significant with MIPs. However, helium MIPs have 
been shown to excite non-metals and halogens due to the high excitation temperature 
as well as through charge transfer2,7.
Figure 3. Quartz torch utilized to contain plasmas .
Inductively coupled plasmas (ICPs) were introduced in the mid-1960s in the
O Q
works of Greenfield, Berry, and Jones and Wendt and Fassel . ICPs are maintained 
by an electromagnetic field sustained with an induction coil. The plasma is also 
contained within a quartz torch (Figure 3). Temperatures of up to 10,000 K can be 
attained with argon ICPs. Figure 4 details the temperature zones within a typical 
argon ICP. Advantages of an argon plasma include high gas temperatures leading to 
efficient atomization, excitation, and ionization as well as a chemical environment 
which reduces interference effects. The residence time of the analyte is typically on 
the order of milliseconds. Argon plasmas accept analytes as nebulized solutions and 
gases. Drawbacks to ICP behavior may include atomic emission spectral overlaps
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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and high operating costs due to the high volume of argon used2. ICPs may also 
become unstable or be extinguished when the matrix contains an organic solvent. 
Desolvation of the analyte stream prior to introduction into the ICP is often necessary 
to analyze samples with these matrices.









Figure 4. Temperature profile of an inductively coupled plasma10
The research presented in this dissertation utilizes an argon ICP as a source 
for atomic emission and mass spectrometry. The following sections will briefly detail 
the pertinent theories and instrumental apparatus utilized in atomic emission and mass 
spectrometry employing ICP as the source.
Inductively Coupled Plasma Atom ic Em ission Spectroscopy
Atomic emission spectroscopy involves the radiative relaxation of a 
population of atoms from an excited to a lower energy level. The process is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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illustrated in Figure 5. An excited state population density, the number of atoms 
per cm3 existing in the ith excited state, (hj), can be calculated using the Boltzmann
• ♦ ♦ 9distribution :
_ E>
n,  = (1.1)
Z ( T )
3 « •where nt is the total number of atoms per cm , g, is the degeneracy of state i, Ej is the 
energy of the state above the electronic ground state, k is Boltzmann’s constant, T is 
the absolute temperature, and Z(T) is the partition function.
The emission intensity (Oy) of an electronic transition from the ith to the j th 
state is expressed in the following equation2:
= A y h V y n ;V  (i.2)
where Ay is the transition probability of an atom from state i to state j, h is Planck’s 
constant, vy is the frequency of photons emitted, n, is the population density of 
excited state atoms, and V is the observed volume element in cm3. A linear 
correlation between <£>y and the analyte concentration in the sample is desired in 
atomic emission spectrometry. This relationship is observed over several orders of 
magnitude with ICP-AES.
Figure 6  illustrates the pertinent ICP-AES components. The figure shows a 
lateral plasma viewing configuration although an axial configuration may also be
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Excitation Emission
Figure 5. Atomic emission energy level diagram showing atomic excitation and 
emission transitions. Ae is the wavelength of emission, h is Planck’s constant, c is the 
speed of light in a vacuum, and E is the energy of the state an atom is in.














Data Acquisition and 
Processing
Figure 6 . Schematic of an ICP-AES instrument.
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utilized. The sample introduction step will be discussed in a separate section.
Optics are used to focus an image of the ICP spectrometer. The spectrometer 
disperses and isolates radiation of the analytical zone of the plasma. The 
spectrometer may be scanned to acquire the background and analyte atomic emission 
signal. For ultraviolet and visible regions of the spectrum, a photo-emissive detector 
such as a photomultiplier tube (PMT) is utilized.
ICP-AES is generally utilized to analyze samples in solution, although the 
analysis of solids may be accomplished via special sample introduction techniques 
such as electrothermal vaporization and spark ablation. The lowest limits of detection 
are typically obtained for metals because they have lower excitation energies 
compared to nonmetals. Nonmetals are not sufficiently excited in an argon plasma to 
yield ultraviolet or visible emission lines of sufficient intensity to be analytically 
useful.
Advantages of ICP-AES include sub-part per billion metal detection limits, 
large dynamic ranges, high reproducibility, and resistance to matrix interferences. 
However, the technique is not without problems. As noted earlier, atomic emission 
spectra can produce spectral overlap interferences due to the large number of atomic 
emission lines present. Calibration curve rollover may also occur at high analyte 
concentrations. Lastly, multi-element analysis may be time consuming if a scanning 
monochromator is used.
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Inductively Coupled Plasma Mass Spectrometry
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With inductively coupled plasma mass spectrometry (ICP-MS), analyte ions 
formed in the plasma are sampled and separated based on their mass-to-charge ratio 
(m/z) with a mass analyzer. While doubly ionized atoms may be formed in the 
plasma, the majority of analyte ions will be singly charged and present at their 
nominal isotopic masses. Figure 7 shows a diagram of a typical ICP-MS instrument 
and the interface region. Like ICP-AES spectrometers, ICP-MS instruments typically 
accept nebulized liquid analytes, although gas and solid samples may be analyzed as 
well11,12. The interface between the atmospheric plasma and the high vacuum mass 
spectrometer is accomplished by a staged transition beginning in the interface region. 
Sample and skimmer cones extract analyte ions formed in the plasma and transfer the 
ions into the intermediate region of the ICP-MS. The gas orifices of the sample and 
skimmer cones typically have diameters of 1.0 and 0.7 mm, respectively. The 
intermediate region contains a series of conducting discs called ion lenses. The ion 
lenses focus the ions from the interface region for transmission to the mass analyzer. 
Turbomolecular pumps provide the gas extraction necessary to achieve pressures 
down to 10' 7 mbars. The mass analyzer is typically a quadrupole with a resolution of 
approximately 300. This is sufficient for discrimination of ions based on unit mass 
differences. Higher resolution mass analyzers such as double focusing sector 
analyzers or time of flight analyzers have been employed to isolate the analyte ions of 
interest in special applications. Common detectors include the Faraday cup, discrete 
dynode detector, and channel electron multiplier. Argon gas flow rates and plasma
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Figure 7. Schematic of an ICP-MS instrument and the interface region10.
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forward power levels greatly influence the position of this analytical zone and 
careful optimization is necessary when instrumental parameters are changed.
The analytical signal output from the detector is directly proportional to the 
concentration of analyte ions formed in the plasma. The fraction of atoms ionized
'y
can be calculated using the Saha equation :
lo g ^  =15.684+log M*
JM
+ - lo g (T ) -5Q4(E^  
2 T (1.3)
Here K; is the ionization constant defined as the ratio of ions ( nM+) and electrons 
( ne ) to ground state atoms (nu ):
ZM+ and ZM are partition functions for the ion and ground state atom, and Eion is the
1 3ionization energy in units of eV. Houk calculated the ionization efficiency for 
elements in the periodic table with a 7500 K plasma and an electron density of 
1015/cm3. These results indicate that most metals are ionized greater than 90%. Table 
3 lists some of the ionization energies for select metals, semi-metals, and nonmetal 
elements.
Advantages of ICP-MS are superior sensitivity and a large dynamic range for 
a large number of elements. Detection limits in the part per trillion range have been 
reported for a number of elements14. Interferences present at an analyte’s isotopic 
mass raise the background ion current, negatively affecting the sensitivity of the
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Table 3. Ionization energy of selected metals 
and non-metals.
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instrument. Careful matrix matching and sample preparation are necessary to 
ensure optimal performance.
Considerations for Pharmaceutical Analysis
Atomic Spectrometry of Nonmetals
The sensitivity and robustness of ICP-AES and ICP-MS to a number of 
elements have been utilized in a number of environmental15,16, regulatory17,
1R 90 91 99industrial ' , and pharmaceutical ' applications. A majority of the applications 
have been directed at monitoring samples and determining concentrations based on 
the metal content of an analyte. This is due primarily to the greater sensitivity of 
these techniques towards metals. The recent incorporation of nonmetal heteroatoms 
such as phosphorus, sulfur, chlorine, and fluorine into pharmaceutical drugs has 
brought renewed interest for designing nonmetal selective detection methods.
Specific applications of interest to the pharmaceutical industry include 
impurity profiling, monitoring of degradation products, and regulatory compliance 
issues. A starting point in designing an instrumental method for sensitive non-metal 
detection is identifying the selectivity and sensitivity requirements of the system.
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ICP-AES and ICP-MS Utilizing High Performance Liquid Chromatography
ICP-AES and ICP-MS are element-specific detection techniques. They 
respond to the presence of a specific element within a nebulized solution regardless of 
its source. The presence of two compounds or more with similar elemental 
composition occurs frequently in a pharmaceutical synthesis environment. The active 
pharmaceutical ingredient (API) may contain the same heteroatoms as an impurity, as 
a degradation byproduct, or as a result of side reactions during or following API 
synthesis.
High performance liquid chromatography (HPLC) has become a standard 
separation method in the pharmaceutical industry due to its ability to separate non­
volatile polar and non-polar compounds. 2 4 ' 3 0  Separation of polar compounds is 
typically performed using reverse phase chromatography. Separation of non-polar 
compounds is often accomplished using normal phase chromatography. Volatile
* T1compounds may be separated utilizing gas chromatography ' . A large number of 
pharmaceutical compounds are non-volatile in nature and contain heteroatoms. This 
research focuses on the development of ICP-AES and ICP-MS as an element-specific 
nonmetal detector for HPLC with applications in the pharmaceutical industry.
Standard detection systems for HPLC include ultraviolet detectors (UV) and 
electrospray mass spectrometry (ESI-MS). Both have proven to be robust and 
sensitive detection methods for pharmaceutical analysis. However, drawbacks to 
these detection methods exist. Detection by UV absorption requires the presence of a 
chromophoric moiety. Response factors are different for all analytes, requiring
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calibration standards for each. Detection by ESI-MS suffers when the analyte 
molecules possess poor ionization characteristics. Additionally, ESI-MS requires a 
volatile matrix. This factor limits the range of chromatographic buffers that can be 
used. ICP-AES and ICP-MS detection has the potential to be a complementary 
detection technique when ESI-MS or UV detection is not feasible.
Interfacing ICP-AES and ICP-MS to HPLC can be achieved by connecting 
the outflow of liquid from the HPLC column to the sample introduction system. A 
low volume connection is used to limit post-column chromatographic band 
broadening of the analyte. ICP-AES and ICP-MS may be used in tandem with UV 
detection.
Analytical figures of merit pertinent for chromatographic systems include the 




where tr is the retention time of the analyte peak and W0 .5 is the width of the peak at 
half the peak maxima. The number of theoretical plates is an indication of column 
efficiency. The minimum number of plates required for regulatory purposes in the 
pharmaceutical industry is 2000 .
Adequate separation of one component from another is necessary and is 
measured by the resolution (Rs) calculated between two chromatographic peaks. The 
standard resolution equation is given below:
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2
where tr 2  and tri are the retention times of the two components and Wbi and Wb2 are the 
baseline widths of the peaks. A minimum resolution of 0.8 is required for the 
pharmaceutical industry35.
Peak tailing factors are an additional figure of merit monitored by regulatory 
agencies. Figure 8 illustrates the method by which tailing factors are calculated.
Tailing factors between 0.5 and 2.0 are required in the pharmaceutical 
industry for acceptable HPLC peak shape.
Interference Considerations for ICP-AES and ICP-MS
Interferences are of great concern with all analytical instrumental techniques. 
Plasma sources generally have lower chemical and matrix-based interferences 
compared with other atomizing techniques. For ICP-AES, the principal concern 
when operating near the instrumental detection limit arises from the high background 
due to blackbody radiation and broad molecular spectral features from solvent 
recombination of argon or other matrix ions that create broad molecular emission 
lines37. Spectral overlap is also of great concern due to the numerous atomic lines 
present for many elements in the periodic table. Judicious choice of the proper
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Tailing Factor
TF = AB / 2AC
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Figure 8. Tailing factor calculation36
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atomic line for the element of interest and careful control of the matrix are 
necessary to ensure that no spectral overlap is present.
Due to the enhanced sensitivity of ICP-MS compared to ICP-AES, 
interference considerations take on added import. Spectroscopic interferences for 
ICP-MS arise due to the presence of interfering ionic species. Typical ICP-MS 
spectrometers utilize a quadrupole mass analyzer with resolutions of approximately 
300. These lower resolution instruments make differentiating an analyte ion of 
phosphorus at mass 30.974 and a background interferent such as 14N n O+ at mass
31.002 impossible.
There are three principal types of interferences that will be of concern in this 
research discussion. The above-mentioned interference of phosphorus is an example 
of a polyatomic ion interference. Polyatomic ion interferences, such as those 
mentioned in the previous paragraph, are generally formed in the cooler or post­
plasma regions. The sources of these interferences are sample matrix species and the 
atmospheric entrainment. Tables of polyatomic interferences are available in the 
literature38*40. Isobaric interferences for a quadrupole mass analyzer occur when two 
elements have isotopes that have less than a mass unit difference between each other. 
This is the case for 40Ca+ (96.94% abundant) at mass 40.078 and the 40Ar ion at mass 
39.948. The determination of calcium would have to be performed at another one of 
its isotopes such as 44Ca+ (2.09% abundant), to avoid the large background from the 
argon ions present to sustain the plasma. The formation of oxides and hydroxides 
ions with the analyte or matrix is another potential interference that can either cause 
spectral overlap or the shifting of the analyte ion of interest to a different mass41.
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There are several methods available to the analytical atomic spectroscopist 
to attempt to mitigate the effects of the interferences. Meticulous matrix matching 
allows blank subtraction. Careful optimization of gas flow rates, ICP power levels, 
and sample introduction conditions can significantly reduce the formation of 
polyatomic interferences and oxide formation . Instrumental solutions are available 
for ICP-MS. The use of high resolution mass analyzers41,42 can be employed to 
successfully isolate an analyte ion from an interferent. Collision or reaction cells43,44 
positioned prior to the quadrupole region allow for removal of polyatomic ions 
formed after the plasma by collision with an inert gas such as helium. This affords 
the removal of polyatomic interferences from the analytes mass to isolate the analyte 
mass of interest or remove polyatomic interferences. The utilization of non-standard 
sample introduction systems that provide additional solvent removal yields a cost- 
effective means to limit spectroscopic interferences and enhance sensitivity.
Sample Introduction Techniques 
Membrane Desolvation. Pneumatic Nebulization, and Ultrasonic Nebulization
One of the most important aspects in elemental plasma techniques is the 
sample introduction step. The research presented in this dissertation deals with the 
aspiration of liquid sample via a nebulizer. Consequently, the focus for this 
discussion of sample introduction will be on the comparison of standard pneumatic
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nebulizers that appear on a majority of ICP-AES and ICP-MS instruments with 
ultrasonic nebulizers.
Inductively coupled plasmas benefit from the introduction of an efficiently 
nebulized and desolvated analyte within a narrow and homogenous droplet size 
distribution. This allows the thermal energy of the plasma to be effectively utilized 
for the analyte atomization and excitation or ionization of the pure analyte sample. 
Desolvation of the analyte stream will aid in limiting the formation of polyatomic and 
oxide based interferences in the plasma.
Pneumatic nebulizers utilize the Bernoulli effect, where a gas flow at high 
pressure draws a liquid solution through a capillary where it is converted into a mist 
of droplets at the capillary tip. Liquid uptake rates using standard pneumatic 
nebulizers are generally between 1 and 3 mL per minute. The aspirated liquid is sent 
to a spray chamber that excludes large droplet diameters (>10 pm) and may also be 
cooled to aid in desolvating the analyte stream. It has been shown that standard 
pneumatic nebulizers and spray chambers suffer from poor transport efficiency and 
memory effects45,46.
Ultrasonic nebulizers accept liquid sample at an uptake rate between 0.5 to 3.0 
mL/min. The liquid is directed onto a quartz faceplate that oscillates via the 
piezoelectric effect producing a nebulized aerosol with a droplet diameter described 
by the Lang equation47:
(1.7)
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where D is the mean droplet diameter, a  is the surface tension of the liquid, p is the 
liquid density, and v is the transducer frequency. The ultrasonic nebulizer creates a 
dense and homogeneous aerosol that has high transport efficiency to the plasma.
After nebulization, the analyte stream is carried by an argon gas flow through a 
heated J-tube where water and solvent are volatilized from the analyte. Subsequent 
passage through a cooled condenser region allows condensation of the solvent. 
Ultrasonic nebulizers efficiently nebulize both analyte and matrix elements. 
Additional desolvation is sometimes utilized and is often accomplished with a 
membrane desolvator. The membrane desolvator removes additional solvent by 
osmotic pressure-induced diffusion through a microporous PTFE membrane to a 
region continuously swept by a dry external countercurrent gas stream. The dry 
analyte stream exits the membrane desolvator (MD) and is sent to the plasma for 
atomization and ionization. Figures 9 and 10 illustrate the USN-MD sample 
introduction system and additional desolvation in the MD, respectively.
Advantages of USN-MD Sample Introduction
There are several advantages to utilizing a USN-MD sample introduction 
system as compared to the standard pneumatic nebulizers. The USN is more efficient 
than pneumatic nebulizers. This allows a greater flux of analyte to reach the 
plasma47"49. The dual desolvation step removes matrix elements, helping to reduce 
the background ion counts by limiting potential interferences50,51. The desolvation 
also benefits ionization of the analyte by removing solvent that may cool the plasma
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Figure 9. Ultrasonic nebulizer and membrane desolvator (adapted from
Cetac Technologies52).






. ■ ■ ■ a 'flf........
1









Figure 10. Membrane desolvator (adapted from Cetac Technologies52).
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and inhibit efficient excitation or ionization. Lastly, USN-MD allows for the 
determination of analytes in organic solvents. Plasmas may become unstable or 
extinguish when there is excessive solvent load necessitating the addition of oxygen 
to the nebulizer gas or additional desolvation. The ability to analyze samples in 
solvent-based matrices greatly extends the applicability of ICP-AES and ICP-MS as a 
detector for HPLC.
Additional Considerations Concerning USN-MD Sample Introduction
USN-MD sample introduction systems introduce heating and cooling 
elements that may have deleterious effects on volatile analytes. Montaser, Kahen, 
and Jorabchi53 noticed non-linearity in the calibration plot of ammonium bromide 
with membrane desolvation, determining that analyte loss occurred principally in the 
membrane desolvation step. Optimization of USN-MD temperature and gas flow 
rates may aid in limiting analyte loss. Encapsulating the analyte as a thermally stable 
particulate has been demonstrated by Carnahan and Das54, allowing retention of an 
analyte through the membrane by post-column addition of H2 SO4 . Lastly, standard 
ultrasonic nebulizers can accommodate flow rates down to a minimum of 500 
pL/min, limiting their application to standard analytical columns and flow rates.
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It has been stated previously that the analytical detection methods used in this 
research are not as sensitive toward non-metal elements. The most stringent detection 
requirements in the pharmaceutical industry pertain to impurity analysis such as the 
detection of isopropyl methanesulfonate (IPMS) shown in Figure 11. This compound 
and other impurities need to be detected in a range of 5 to 500 parts per million 
relative to the API. This corresponds to a detection level of 10-1,000 ppb for the 
impurity if the API is present at a concentration of 2 parts per thousand.
o
II H
H 3 C s  0  —  ^  C  H 3
O C H 3
Figure 11. Isopropyl methanesulfonate.
To ascertain whether these detection limits are obtainable, our research group 
performed an ICP-MS detection limit study on the model heteroatom-containing 
compounds shown in Figure 12. The results are summarized in Table 4. Sensitive 
nonmetal detection was obtained for sulfur-, phosphorus-, and chlorine-containing 
analytes. The sensitivity of the instrumental method towards fluorine was markedly 
lower, yet this detection limit is one of the lowest reported in the literature for 
fluorine55. Calibration curves with a high degree of linearity have been obtained for 
these compounds utilizing USN-MD-ICP-MS (Figures 13-16).
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Figure 13. Calibration plot for phosphorus as phosphomycin.
y = 1734x + 5175.9 
R2 = 0.9991
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Figure 14. Calibration plot for sulfur as amoxicillin.
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Figure 15. Calibration plot for chlorine as chlorpropamide.
y = 36.307x - 2723.7 
R2 = 0.9994
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Figure 16. Calibration plot for fluorine as ofloxacin.
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Sensitive non-metal detection has been demonstrated utilizing ICP-MS toward 
sulfur-, phosphorus-, chlorine- and, fluorine-containing analytes55. Applicability of 
this technique toward analysis of mixtures of pharmaceutical products can be 
investigated by a systematic study of the effect of mobile phase additives and solvent 
combinations on the analytical figures of merit for a representative nonmetal- 
containing analyte. Studies will be performed with ICP-AES and ICP-MS on the 
phosphorus-containing antibiotic phosphomycin. The purpose of this initial 
investigation is to define what mobile phase solvent combinations and additives lead 
to the most robust and sensitive non-metal determinations for plasma-based detection. 
Additionally, the effect of doping the nebulizer gas flow with oxygen, nitrogen, and 
helium will be examined. Oxygen is commonly added to the nebulizer gas flow 
stream to mitigate the formation of carbon deposits on the sample cone when organic 
matrices are nebulized. The effect on the sensitivity towards nonmetal analytes was 
quantified when USN-MD was the method of sample introduction. The addition of 
nitrogen and helium to the argon gas flows has been reported to enhance the 
sensitivity towards nonmetal-containing analytes. A plurality of experiments bleeds 
these dopants into the auxiliary and coolant gas flows. The effect on the analytical 
figures of merit of bleeding nitrogen and helium into the nebulizer gas stream was 
experimentally determined. Finally, the application of USN-MD-ICP-MS as a 
detector for HPLC will be demonstrated. Several ongoing experiments will be 
highlighted.
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CHAPTER 2
STUDY OF SELECTED BUFFER AND MOBILE PHASE COMBINATIONS ON 
ANALYTICAL FIGURES OF MERIT FOR USN-MD SAMPLE INTRODUCTION
FOR ICP-AES AND ICP-MS
Buffers in Reversed Phase HPLC
Separation in reversed phase HPLC is dependent on the hydrophobicity of the 
analyte. Analytes with a greater degree of hydrophobicity will be retained longer 
than another analyte. If the analyte molecule is ionizable, small changes in the pH of 
the solution may greatly affect the elution time. For example, an analyte molecule 
that is acidic in nature will lose a proton and be ionized when the pH of the solution is 
raised to a sufficient level. The ionized analyte molecule is less hydrophobic, leading 
to a reduced retention time. A large number of molecules separated in reversed phase 
HPLC are ionizable, thus the incorporation of buffers into the mobile phase allows for 
reproducibility and control of retention times and resolution.
Proper selection of an HPLC buffer is dependent on a number of variables, 
including the desired pH of the mobile phase solution. Buffering capacity is greatest
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at the pKa of the buffer (Figure 17)56. If a highly selective method for the 
separation of a component mixture required a pH of 7.0 for the mobile phase, a buffer 
with a pKa value near 7.0 would be desired. The pK^ value of phosphoric acid is 7.2 
and would be a proper choice of buffer for this pH level. Selecting a buffer with a 
pKa value within 1 pH unit of the desired mobile phase pH will yield an acceptable 
buffering capacity62. Table 5 lists some common HPLC buffers with their associated 
pKa values and useful pH ranges.
The pKa and pH values of the buffer/mobile phase are not the only criteria for 
proper buffer selection. The compatibility of the detection method with the buffer 
and mobile phase must be taken into consideration. For example, when utilizing UV 
detection of HPLC separated analytes, it is important to consider the cutoff 
wavelength where the buffer/mobile phase begins to strongly absorb UV light. 
Obtaining sensitive detection for an analyte that has a chromophore absorbing at 210 
nm is not possible if the buffer in the matrix strongly absorbs at wavelengths less than 
215 nm. Additionally, as noted previously, ESI-MS only accepts buffers that are 
volatile. Using nonvolatile buffers such as phosphates would not be feasible.
Pharmaceutical Application of Examining Chromatographic Buffer and Mobile Phase 
Combinations for Heteroatom Detection by ICP-AES and ICP-MS
Many pharmaceutical compounds are comprised of small molecules 
containing carbon, hydrogen, oxygen and nitrogen. The vast majority of these
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Table 5. Common HPLC buffers57.
Buffer__________________ gKa_______________ Buffer Range
Phosphate 2.1 1.1 -3.1
7.2 6.2-8.2
12.3 11.3-13.3
Formic acid 3.8 2.8-4.8
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analytes speciated with reverse phase HPLC may be detected with classical liquid 
chromatography detectors such as UV or ESI-MS. Research and development 
initiatives, brought on by the drive for new medications, have seen the incorporation 
of heteroatoms such as sulfur, phosphorous, chlorine and fluorine into pharmaceutical 
compounds and impurities. Plasma-based detection methods offer an alternative 
approach to detecting these compounds.
However, analytical chemists in the pharmaceutical industry may approach 
the coupling of HPLC to ICP-AES or ICP-MS from an HPLC-UV or HPLC-MS 
detection scheme perspective. For example, users of traditional HPLC-ESI-MS 
systems must use volatile mobile phase buffers such as trifluoroacetic acid or formic 
acid. Would adding a less volatile salt such as perchlorate to an ICP-based system be 
an issue, as it would be with HPLC-ESI-MS? The possible effects of the mobile 
phase and buffer composition, such as ionization and/or emission quenching, deserve 
investigation.
With ICP techniques, it has been previously shown that a large percentage of 
organic solvent is successfully removed utilizing membrane desolvation. Figure 18 
shows the background emission spectrum for a methanol solution nebulized into a 
He-MIP. The top spectrum is without membrane desolvation and shows prominent 
solvent emission features of C2 , CN, OH, and C(I). With membrane desolvation, 
these features are greatly reduced, indicating efficient desolvation. However, 
desolvation is not 100%. Any remaining organic solvent and buffer may have a
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Figure 18. Methanol background emission spectrum with (top) and without (bottom)
membrane desolvation in a He-MIP54.
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measurable impact on plasma stability and background signal intensity. This is 
especially true for ICP-MS since it is a much more sensitive technique.
Finally, it is important to establish the sensitivity trend across a range of 
organic mobile phase compositions. HPLC separations take advantage of gradient 
programming that allows the chromatographer to change the eluting power of the 
mobile phase. A large change in detector sensitivity across a gradient is not desirable, 
as either multiple calibration standards would be required for different mobile phase 
compositions or only isocratic elution would be possible.
The study presented here is designed to determine which mobile phase and 
buffer solvent systems lead to sensitive nonmetal determinations. The results of such 
a study will allow the chromatographer to design an HPLC method utilizing a buffer 
and mobile phase that is ICP-AES and/or ICP-MS friendly and yields sensitive 
determinations. Phosphorus as phosphomycin was examined both by ICP-AES and 
ICP-MS. Phosphorus was chosen as the model analyte based on the ability to detect 
it by both AES and MS.
Experimental 
ICP-AES Instrumentation
Nebulized and desolvated analyte was directed to a Model 2.5 Leeman 
Laboratories (Hudson, NH) 27 MHz ICP. The image of the ICP was laterally focused 
upon a Model 1000 SPEX (Edison, NJ) 1 m focal length monochromator equipped
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with a 1200 groove/mm grating. Entrance and exit slits were set at 25 pm.
Phosphorus emission at 253.8 nm was monitored with a Hamamatsu (Middlesex, NJ) 
R928 photomultiplier tube biased at -850 V and SPEX DataScan2 hardware with 
software Version 1.5.4.0. Integration time was 250 ms. A schematic of the ICP-AES 
experimental system is shown in Figure 19. The operating parameters are detailed in 
Table 6.
ICP-MS instrumentation
A Fisons (Thermo Electron) Instruments PlasmaQuad I I 27 MHz ICP-MS was 
used. Ion signals from a Burle (Sturbridge, MA) Channeltron 4870V were acquired 
utilizing Thermo Electron PlasmaLab software (Version 1.06.007, Ionflight, Boston,
31
MA). Mass spectra were obtained to confirm the peak position for P. Single ion 
monitoring of peak intensities was used for quantification and the dwell time was set 
for 250 ms. A schematic diagram of the ICP-MS experimental system is shown in 
Figure 20. Detailed operating parameters are listed in Table 7.
Reagents and sample preparation
Phosphorus-containing solutions were prepared by dilution o f  a stock solution 
containing phosphomycin calcium salt in 18 MQ deionized water. Solvents included 
aqueous-organic mixtures containing methanol or acetonitrile. The nine buffer salts,

























Figure 19 Schematic diagram o f  experimental setup for ICP-AES
-Pi-On
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Table 6. ICP-AES operating parameters. 
_________________________ Operating Parameters__________
Peristaltic pump flow rate (mL/min) 1.0
Nebulizer flow rate (L/min) 0.78
Nebulizer heater temperature (°C) 140
Nebulizer condenser temperature (°C) 3
Membrane desolvator temperature (°C) 140
Membrane desolvator countercurrent gas 0.51
flow rate (L/min)
Argon plasma gas flow rate (L/min) 13.0
Argon intermediate gas flow rate (L/min) 0.1
Applied plasma power (W) 1250















































Table 7. ICP-MS operating parameters. 
________________________ Operating Parameters________
Peristaltic pump flow rate (mL/min) 0.9
Nebulizer flow rate (L/min) 0.62
Nebulizer heater temperature (°C) 140
Nebulizer condenser temperature (°C) 3
Membrane desolvator temperature (°C) 160
Membrane desolvator countercurrent gas 1.9
flow rate (L/min)
Argon plasma gas flow rate (L/min) 14.0
Argon intermediate gas flow rate (L/min) 0.8
Applied plasma power (W) 1000
Flow injection volume (mL) 0.1 -0.2
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their formulations, applicable acronyms, concentrations and other reagent data are 
listed in Table 8.
Sample Introduction
Liquid samples were nebulized using a CETAC U5000 USN (CETAC 
Technologies, Omaha, NE) introduced by a Gilson Minipulse 3 peristaltic pump 
(Gilson, Inc., Middleton, WI). Upon exiting the USN condensation apparatus, the 
nebulized mist was directed through a CETAC MDX-100 polytetrafluroethylene 
(PTFE) membrane desolvator. The desolvated samples were then transported to the 
plasma.
ICP-AES Results
Solutions containing phosphorus (4 ppm) as phosphomycin were directed to 
the USN. The atomic emission spectrum of phosphomycin is shown in Figure 21. 
Phosphorus emission signals, background intensities and background noise were 
measured for aqueous solutions containing 0, 20, 50 and 80% organic mobile phases 
and each buffer. Results are reported as the average of triplicate runs. Detection 
limits (DL) and limits of quantification (LQ) were defined as analyte concentrations 
producing signals 3 and 10 times the standard deviation of the background noise, 
respectively. Results are summarized for methanol and acetonitrile mobile phases in 
Tables 9 and 10, respectively.

















Table 8. Solvents and buffers utilized.
Compound (acronym); aqueous solution Formula Grade Manufacturer
concentrations
M ethanol (M eOH) CH-OH FIPLC Grade Fisher Scientific (Pittsburgh, PA)
Acetonitrile (ACX) CH3CX HPLC Grade Fisher Scientific (Pittsburgh, PA )
0 . 1 % formic acid HCOOH >99% Acros Organics (Pittsburgh, PA)
0 .1 % ammonium formate HCOOXFL 99 % Acros Organics (Pittsburgh, PA )
0 . 1  % acetic acid CH 3 COOH Analytical
Grade
Mallinckrodt. Inc. (Paris, KY)
0 .1 % ammonium acetate CH 3 COOXH 4 Reagent Grade Sigma-Aldrich (M ilwaukee, WI)
0.1% trifluoroacetic acid (TFAA) CF 3 COOH 99% Acros Organics (Pittsburgh PA )
7.5mM tetrabutylammonium hvdroxide 
(TBAH)
(C4Ho)4X O H FIPLC Grade Acros Organics (Pittsburgh PA)
0 .2 % perchloric acid h c i o 4 Reagent Grade J.T. Baker Chemical s (Phil lip sburg 
XJ)
0.1%  triethylamine (TEA) (C;H ;)3 X Reagent Grade Fisher Scientific (Pittsburgh, PA)
5mM 1-heptane sodium sulfonate (HEPS) X aSO ;C -H ;; FIPLC Grade Acros Organics (Pittsburgh PA)
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Figure 21. Atomic emission spectrum of phosphomycin.

















Table 9. Phosphorus figures of merit in methanol mobile phases for ICP-AES.
Buffer Sensitivity
(S/ppm)
DL (ppb) LQ (ppb) Buffer Sensitivity (S/ppm) D L (ppb) LQ
(PPb)
0% MeOH 50% MeOH
None 55 150 500 None 53 170 570
0 . 1 % c h 3c o o h 53 150 500 0.1% CH3 COOH 53 180 600
0.1% CH3 COONH4 54 150 500 0.1% CH3 COONH4 54 190 630
0.1% HCOOH 53 150 500 0.1% HCOOH 52 190 630
0.1% TFA 54 150 500 0.1% TFA 54 170 570
0.1% TEA 45 2 0 0 670 0.1% TEA 25 410 1400
0.2% HCIO4 49 160 530 0.2% HCIO4 52 180 600
0.1% HCOONH4 51 160 530 0.1%HCOONH4 54 170 570
7.5 mM TBAH 46 260 870 7.5 mM TBAH 50 2 0 0 670
15 mM HEPS 44 190 630 15 mM HEPS 42 230 770
20% MeOH 80% MeOH
None 59 180 600 None 60 170 570
0.1% CH3 COOH 59 180 600 0.1% CH3 COOH 57 180 600
0.1% CH3 COONH4 58 2 0 0 670 0.1% CH3 COONH4 56 2 0 0 670
0.1% HCOOH 58 180 600 0.1% HCOOH 56 190 630
0.1% TFA 60 180 600 0.1% TFA 58 180 600
0.1% TEA 53 2 1 0 700 0.1% TEA 34 300 1 0 0 0
0.2% HCIO4 56 180 600 0.2% HCIO4 56 180 600
0.1% HCOONH4 58 180 600 0.1%HCOONH4 59 180 600
7.5 mM TBAH 56 240 800 7.5 mM TBAH 41 390 1300


















Table 10. Phosphorus figures of merit in acetonitrile mobile phases for ICP-AES.
Buffer Sensitivity
(S/ppm)
DL (ppb) LQ (ppb) Buffer Sensitivity (S/ppm) DL (ppb) LQ
(ppb)
0% CAN 50% CAN
None 55 150 500 None 65 160 530
0 . 1 % c h 3c o o h 53 150 500 0.1% CH3 COOH 6 6 160 530
0.1% CH3 COONH4 54 150 500 0.1% CH3 COONH4 6 6 170 570
0.1% HCOOH 53 150 500 0.1% HCOOH 64 160 530
0.1% TFA 54 150 500 0.1% TFA 67 170 570
0.1% TEA 45 2 0 0 670 0.1% TEA 43 260 870
0.2% HCIO4 49 160 530 0.2% HCIO4 71 150 500
O.P/0 HCOONH4 51 160 530 0.1%HCOONH4 62 170 570
7.5 mM TBAH 46 260 870 7.5 mM TBAH 28 440 1500
15 mM HEPS 44 190 630 15 mM HEPS 62 180 600
20% CAN 80% ACN
None 40 240 800 None 61 130 430
0.1% CH3 COOH 40 230 770 0.1% CH3 COOH 67 130 430
0.1% CH3 COONH4 39 260 870 0.1% CH3 COONH4 13 660 2 2 0 0
0.1% HCOOH 40 230 770 0.1% HCOOH 65 140 470
0.1% TFA 40 250 830 0.1% TFA 65 140 470
0.1% TEA 27 340 1 1 0 0 0.1% TEA 54 150 500
0.2% HCIO4 39 230 770 0.2% HC104 69 1 1 0 370
0.1% HCOONH4 40 240 800 0 .1 % h c o o n h 4 54 160 530
7.5 mM TBAH 48 240 800 7.5 mM TBAH 49 170 570
15 mM HEPS 37 260 870 15 mM HEPS 57 150 500
55
Detection limits in the range of 150 ppb were obtained when phosphomycin 
was introduced in pure aqueous solution, without any buffer salts. With the 100% 
aqueous solutions, the presence of most buffers did not significantly affect the 
detection limits. Detection limits with six of the buffers remained within 15% of 150 
ppb and are not considered statistically different. For HEPS, TBAH and TEA, the 
detection limits were degraded slightly more. Because these buffers were prepared at 
concentrations normally used in HPLC, the concentrations of HEPS and TBAH (15 
and 7.5 mM) had mass percentages three and two times that of the other buffers 
(0.1%). This mass loading factor may negatively affect the plasma, inhibiting 
excitation, contributing to the detection limit increases seen with those buffers. In 
general, the intensities of the background remained constant, regardless of the 
solution composition.
In most cases, the addition of buffers caused signal depression. This 
depression is probably caused by a combination of “de-tuning” of the plasma caused 
by organic loading and effects of analyte nebulization and transport through the 
sample introduction system. Membrane desolvation works well for lower boiling 
point solvents and buffers such as methanol and formic acid. Higher boiling point 
buffer salts tend to be retained through the desolvation process. However, the 
suppression is moderate and was greatest when HEPS, TBAH and TEA buffers were 
utilized.
To examine the response factors as a function of solvent composition, 
analytical sensitivity was examined over a range of organicraqueous solvent 
concentrations. A plot of sensitivity versus organic phase content for methanokwater
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solutions is shown in Figure 22. Sensitivity data is tabulated in Table 9 for all 
methanokwater mobile phase combinations. Figure 22 shows a general trend of 
signal depression for the 20% methanol solutions compared to the 100% aqueous 
mobile phase. For most buffers, phosphorus signals increase as the mobile phase 
organic content increases to 50%. Greater enhancement is found with 80% methanol 
mobile phases. It is likely that depression and enhancement effects are caused by 
differences in solution viscosity, surface tension and the ability of the USN to 
nebulize these solvents with varying methanol compositions. Except for the solutions 
containing TEA, ammonium formate and perchloric acid, signals remained within 
10% of the signal with the buffer and 100% water. The signal with TEA was 
depressed by 25% with 80% methanol and the signal with perchloric acid was 
enhanced by 14% with 80% methanol. The relative stability of sensitivity factors 
across a range of organic mobile phase compositions indicates that solvent 
programming should be possible, in most cases, while retaining the response integrity 
of the system.
The corresponding study with waterracetonitrile mixtures is listed in Table 10. 
Sensitivity as a function of acetonitrile mobile phase composition is shown in Figure 
23 with three of the nine buffers. In general, as with the water:methanol solutions 
there is a trend that the 20% organic:water solutions produces a signal suppression. 
However, the suppression is noted to be much larger than with the 20% 
methanokwater solutions, averaging 23%. Compared to solutions with no 
acetonitrile, signals with 50 and 80% acetonitrile exhibit sensitivity enhancements of 
an average of 18 and 10%, respectively. Within these groups are several outliers. For

























Figure 22. ICP-AES phosphorus sensitivity as a function of methanol composition.
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Figure 23. ICP-AES phosphorus sensitivity as a function of acetonitrile composition.
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example, perchloric acid and HEPS produce exceptionally large enhancements 
(61-73%) with 50 and 80% acetonitrile. It is likely that these prominent differences 
between methanol and acetonitrile are caused by significant changes in nebulization 
characteristics. Higher acetonitrile mobile phase compositions nebulized very 
efficiently, evidenced by visual inspection of the USN spray chamber. In 
comparison, higher methanol mobile phase compositions were not nebulized as 
efficiently, creating a mist that was visibly less dense within the spray chamber.
In summary, detection limits for phosphorus as phosphomycin utilizing ICP- 
AES are on the order of 140-200 ppb, with a variety of buffers and solvent 
compositions. Buffers, in general, have a tendency to produce a depression in 
sensitivity. The most significant sensitivity effects are found with TEA, ammonium 
formate and perchloric acid buffered solutions. Effects of the methanolrwater 
composition upon signal intensity are minimal. Although solvent gradient response 
varies significantly with the 0.1% TEA buffer, the average standard deviation for the 
remaining buffers is 6.1% and less than 5% for four of the buffers. It is likely, then, 
that LC solvent programming can be done without the need for recalibrating the 
response of the instrument as a function of the methanol: water ratio. Effects of the 
acetonitrile:water composition upon signal intensity are more significant. The 
average standard deviation of the sensitivity for all buffers in acetonitrile mobile 
phases is 26%. The standard deviation for solutions with no buffer is 20%. It is 
unlikely that LC solvent programming can be done reliably without the need for 
recalibrating the response of the instrument as a function of the acetonitrile. water 
ratio.
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ICP-MS Results
Solutions containing the appropriate buffer and aqueous:organic solvent were 
nebulized. The phosphorus signal at mtz 31 was monitored and recorded to obtain the 
analyte signal, background and associated background noise. Figure 24 displays a 
typical mass spectrum obtained when deionized water background (blue) and 
phosphorus as phosphomycin (green) is nebulized. Results are reported as averages of 
triplicates. Using flow injection, 0.1-0.2 mL of phosphomycin-containing solutions 
were nebulized and desolvated. Tables 11 and 12 summarize the results for the 
methanol and acetonitrile-containing mobile phases, respectively. The absolute 
(mass) detection limits obtained for all buffers in each aqueous:organic solvent 
mixture for methanol and acetonitrile are graphically presented in Figure 25 and 26, 
respectively.
Sensitivity as a function of mobile phase composition for all buffers was 
examined as in ICP-AES experiments. Figures 27 and 28 demonstrate the effect on 
sensitivity for methanol and acetonitrile concentration gradients, respectively. A 
significant decrease in sensitivity was noted for both organic phases; however, 
detection limits, shown in Figures 29 and 30 did not similarly degrade. This is 
especially true for the acetonitrile mobile phases.
Table 11 indicates a significant loss of sensitivity once methanol is introduced 
in the solvent system. Figure 25 illustrates a large range of absolute detection limits 
for each buffer. Buffers that most negatively affected detection limits for all mobile
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Figure 24. ICP-MS mass spectrum of background (blue) and phosphomycin (green)
at 31P+.











Table 11. Phosphorus figures of merit in methanol mobile phases for ICP-MS.
Buffer Sensitivity
(icps*/ng)
DL (ng) LQ (ng) Buffer Sensitivity
(icps*/ng)
DL (ng) LQ (ng)
0% MeOH 50% MeOH
None 23000 0.54 1 . 8 None 2 2 0 1 2 40
0.1% CH3COOH 77000 0.29 1 0.1% CH3COOH 2 1 0 13 43
0 . 1 %
CH3 COONH4 7300 3.5 1 2 0.1% CH3 COONH4 270 23 78
15 mM HEPS n.d. n.d. n.d. 15 mM HEPS 34 63 2 1 0
0.1% HCOOH 55000 0.49 1 . 6 0.1% HCOOH 340 6 2 0
0.1% TFA 8200 9.1 30 0.1% TFA 240 1 1 38
0.1% TEA 23000 2.9 9.6 0.1% TEA 2 0 0 24 81
0.2% HC104 97000 0.64 2 . 1 0.2% HCIO4 2 2 0 8 . 8 29
0.1%HCOONH4 42000 0.46 1.5 o . i% h c o o n h 4 330 1 0 33
7.5 mM TBAH 4600 53 180 7.5 mM TBAH 310 150 500
20% MeOH 80% MeOH
None 2 2 0 0 0 0.36 1 . 2 None 800 3.8 13
0.1% CH3COOH 3600 2.4 8 . 1 0.1% CH3COOH 910 5.7 19
0 . 1 %
CH3 COONH4 1500 4.2 14 0.1% CH3 COONH4 710 6.5 2 2
15 mM HEPS 130 33 1 1 0 15 mM HEPS 1 0 0 0 25 82
0.1% HCOOH 1500 14 45 0.1%, HCOOH 800 3.8 13
0.1% TFA 1 0 0 0 26 8 6 0.1% TFA 750 1 1 35
0.1% TEA 1500 15 49 0.1% TEA 400 29 95
0.2% HCIO4 1300 16 53 0.2% HC104 650 3.2 1 1
0.1%HCOONH4 1 0 0 0 8 . 1 27 o . i% h c o o n h 4 630 5.8 19
7.5 mM TBAH 560 6 8 230 7.5 mM TBAH 480 1 1 0 370
n.d.: not detectable under these conditions.











Table 12. Phosphorus figures of merit in acetonitrile mobile phases for ICP-MS.
Buffer Sensitivity (icps*/ng) D L (ng) LQ (ng) Buffer Sensitivity
(icps*/ng)
DL (ng) LQ  (ng)
0% CAN 50% ACN
None 23000 0.54 1 . 8 None 830 0 . 8 8 2.9
0 . 1 % c h 3c o o h 77000 0.29 1 0.1% CH3 COOH 1 0 0 0 1 . 2 4.1
0 . 1 %
CH3 COONH4
7300 3.5 1 2 0.1% CH3 COONH4 1300 1 . 2 4.1
0.1% HCOOH 55000 0.49 1 . 6 0.1% HCOOH 1500 0.54 1 . 8
0.1% TFA 8200 9.1 30 0.1% TFA 1400 0.95 3.2
0.1% TEA 23000 2.9 9.6 0.1% TEA 2 2 0 0 0.48 1 . 6
0.2% HCIO4 97000 0.64 2 . 1 0.2% HC104 1500 1.7 5.6
o . i % h c o o n h 4 42000 0.46 1.5 o . i % h c o o n h 4 1900 0.63 2 . 1
7.5 mM TBAH 4600 53 180 7.5 mM TBAH 2800 2.3 7.6
20% CAN 80% ACN
None 5500 1 . 2 4.1 None 8900 0.54 1 . 8
0.1% CH3 COOH 2 1 0 0 0 0.69 2.3 0.1% CH 3 COOH 4900 0.54 1 . 8
0 . 1 %
CH3 COONH4
4400 4.6 15 0.1% CH3 COONH 4 6200 0 . 8 6 2.9
0.1% HCOOH 3400 1.3 4.2 0.1% HCOOH 9800 0.43 1.4
0.1% TFA 3700 1.9 6 . 2 0.1% TFA 5800 0.72 2.4
0.1% TEA 3400 1 3.5 0.1% TEA 3600 0.41 1.4
0.2% HCIO4 49000 1 . 2 4 0.2% HC104 6300 0.69 2.3
0.1% HCOONH4 8600 1 3.5 0.1%HCOONH4 6200 0.51 1.7
7.5 mM TBAH ND ND ND 7.5 mM TBAH 2 1 0 0 3.7 1 2
ND: not detectable under these conditions.
* Ion counts per second.
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□  0% MeOH 
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□  80% MeOH
Figure 25. ICP-MS phosphorus detection limits as a function of methanol 
concentration with various buffers.
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Figure 26. ICP-MS phosphorus detection limits as a function of acetonitrile 
concentration with various buffers. The detection limit for phosphorus with tetrabutyl 
ammonium hydroxide in 0% acetonitrile is excluded because of the large value. With 
the same buffer and 20% acetonitrile, phosphorus was not detectable.
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Figure 27. ICP-MS phosphorus sensitivity as a function of methanol concentration
for selected buffers.
























Figure 28. ICP-MS phosphorus sensitivity as a function of acetonitrile concentration
for selected buffers.
















Figure 29. ICP-MS phosphorus detection limits as a function of methanol 
concentration for selected buffers.
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Figure 30. ICP-MS phosphorus detection limits as a function of acetonitrile 
concentration for selected buffers.
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phase compositions include ammonium formate, TFAA, TEA and TBAH. The 
buffers that least affected detection limits were acetic acid, formic acid, perchloric 
acid and ammonium formate. Absolute detection limits with each of these buffers 
remained below 20 ng for all mobile phase compositions. Figure 27 demonstrates the 
large drop in sensitivity upon addition of methanol. While signal suppression was 
associated with an increase in detection limits, the increase is not nearly as significant 
as might be expected by the sensitivity drop as seen in Figure 27. Figure 29 indicates 
detection limits for a set of buffers for the methanol: water concentration gradient. It 
is clear that solvent programming will not be possible with methanohwater mobile 
phase compositions. Isocratic separations can still yield sensitive determinations, 
although careful matrix matching is necessary, as background and analytical 
sensitivity vary greatly from one mobile phase combination to another.
While there is some loss in sensitivity upon addition of acetonitrile to the 
aqueous mobile phase solutions, the drop is much less when compared to the 
methanol mobile phases. Table 12 shows the absolute detection limits and sensitivity 
for the acetonitrile mobile phase compositions. Values are in the range of single 
nanograms or less for a majority of the mobile phase compositions. Figure 26 
indicates that TFA, TBAH, TEA and ammonium acetate are the buffers that most 
negatively affect detection limits. The detection limit for aqueous phosphorus with 
the TBAH buffer was excluded because it is large in comparison to the other buffer 
mobile phases. Also, the phosphorus in the 20% acetonitrile:TBAH buffer solution 
was not detectable using the nebulized concentration. This is most likely due to
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decreased nebulization efficiency when 20% acetonitrile solutions were introduced. 
Also, the higher mass loading with the TBAH buffer may be a contributing factor in 
the significant detectability loss at other acetonitrile :TB AH buffer compositions as 
compared to other buffers.
Figure 28 illustrates the drop in sensitivity upon an increase in solvent 
acetonitrile content. However, Figure 30 demonstrates that detection limits for 
acetonitrile:buffer mixtures are less affected as the acetonitrile content increases as 
compared to methanol mobile phase compositions. A potential drawback to using 
acetonitrile-containing mobile phases is the formation of carbon deposits on the 
sample and skimmer cones. This became more substantial as the acetonitrile content 
was increased. These deposits were more pronounced with acetonitrile-containing 
mobile phases as compared to methanol-containing mobile phases and required more 
frequent maintenance. This observation indicates that 100% desolvation of the 
aerosol stream is not achieved. The slower buildup of carbon with methanol- 
containing mobile phases is likely due to the more oxidizing plasma environment 
produced by methanol.
Comparison of ICP-AES and ICP-MS Results
With detection limits in the single ppb range, ICP-MS is much more sensitive 
than AES for phosphorus detection. While this has obvious benefits, the technique is 
also more susceptible to small changes in sample composition. ICP-AES response
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was relatively independent of the matrix solution. The source of potential 
interferents for both techniques is substantially different, as discussed previously.
For ICP-MS it is important to identify possible interferences that may be
31 +present at the analyte ion mass. When monitoring the P isotope, there may be
14 16 1 + 15 16 +
significant interference contributions from N O H and N O . Buffer/solvent 
combinations containing these atoms may have a deleterious effect on the background 
signal and stability. This is especially true for buffers that are relatively non-volatile, 
as an increased percentage will survive to the ICP and potentially contribute to 
matrix-induced interferences. While several of the buffers in this study contain 
nitrogen, only TBAH produced a significant increase in the background ion count. 
Other nitrogen-containing buffers such as ammonium acetate, ammonium formate 
and TEA did not produce a substantial increase in the background ion signal. A 
possible explanation for differences as compared to TBAH may be due to the 
increased mass fraction of the buffer in solution and the lower volatility and, hence, 
increased transport through the desolvator to the plasma.
The USN nebulization efficiency visibly decreased upon increases in the 
fraction of either methanol and acetonitrile. These effects may be caused by viscosity 
and surface tension changes as a function of liquid composition. Any variations in 
sample nebulization will affect the analytical signal intensity. The nebulization 
efficiency changes may help explain the loss in sensitivity upon addition of organic 
solvent. These effects will vary not only with the percent of organic solvent in the 
solution, but also with the nature of the organic solvent. Additionally, differences in 
the physical properties of acetonitrile- and methanol-based solvents such as volatility,
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surface tension, density, thermal conductivity, etc., will alter USN and MD 
desolvation behavior. For example, the boiling point of methanol is 65.5 C while 
that of acetonitrile is 81.6 C.
Lastly, it is possible that the transport efficiency of a semi-volatile analyte 
such as the phosphomycin used in this study may be influenced by the volatility of 
the buffer. For example, if the dry analyte-containing particulate traverses the 
desolvation system in the presence of a low volatility buffer, transport efficiency may 
be affected positively. If, on the other hand, the buffer is of high volatility, it may be 
volatilized and transported through the desolvator to waste, leaving behind less 
“protected” and more surface evaporable analyte. This has been noted in previous 
work conducted in this laboratory54 and deserves additional study. A possible 
experiment to test this would include a low volatility buffer and a high volatility 
buffer that do not significantly contribute to the background ion count and analyte 
compounds of low and high volatility. Obtaining relative response factors for 
combination of low and high volatility buffer and analyte may help deduce the 
relative effect the sample introduction system has on low and high volatility analytes 
and how well buffers can “protect” them from desolvation.
Conclusion
The focus of this study has been to characterize detection behavior as a 
function of various solvent compositions and buffer combinations that may be 
utilized in liquid chromatography. The model system of this study examined
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
74
phosphorus as phosphomycin. Depending on the solvent-buffer combinations, 
detection limits in the range of single parts per billion were obtained with ICP-MS. 
Detection limits were approximately 2 orders of magnitude higher with ICP-AES.
Responses changed minimally as the solvent composition was varied in ICP- 
AES experiments. It appears that within reasonable accuracy constraints, HPLC 
solvent programming can be performed with methanol solvents without instrument 
response recalibration. Sensitivities varied a bit more with water:acetonitrile 
mixtures, but still remained within 20% of that of the pure aqueous solvent.
With ICP-MS, sensitivities decreased significantly as the methanol or 
acetonitrile content was increased. This behavior may indicate that increased organic 
solvent may affect phosphorus ionization more significantly than phosphorus atom 
excitation. As compared to solutions without buffers added utilizing AES, most 
buffers only minimally affected signals and detection limits. Exceptions were seen 
with TEA, TBAH and HEPS. At this point, it is not completely clear why these 
buffers cause significantly more problems. However, the deleterious effects with 
TBAH and HEPS may possibly be due to higher mass loadings with the 
concentrations utilized for the chromatography conditions simulated.
Buffer effects are clearly more significant with ICP-MS. Whether in pure 
aqueous solutions or aqueous-organic mixtures, results were scattered. A number of 
the buffers produced sensitivity enhancements, but a number produced suppression.
It is clear that response calibration is closely related to the nature of the solvent- 
buffer system and that any calibration standards must be closely matched in
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composition. Further studies are needed to determine the fundamental reasons for 
these behaviors.
As the organic mobile phase concentrations are increased, the phosphorus ion 
signal decreases. These effects are more pronounced with the methanol-based 
solvents than with the acetonitrile-based solvents. Nebulization efficiency may play a 
role in the signal reduction at higher organic phase concentrations; however, because 
the signal reduction is less significant, it is more likely that ionization suppression 
effects caused by higher organic solvent concentrations are the cause.
Carbon deposition was more significant with acetonitrile-containing mobile 
phases as opposed to methanol. As noted previously, this may be attenuated by 
bleeding a steady flow of O2  into the nebulizer gas. It is typically suggested that O2 
be continuously bled into the system to minimize damage to the cones and decrease 
the frequency of cleaning. A comprehensive study on the effect of bleeding O2  into 
the nebulizer gas flow needs to be performed to ascertain if this significantly affects 
the sensitivity of the instrument toward heteroatom detection.
In summary, isocratic elution is suggested for HPLC methods involving USN- 
MD-ICP-MS. Gradient elution with ICP-AES is possible with minimal sensitivity 
effects. Several buffers led to sensitive nonmetal determinations for both ICP-AES 
and ICP-MS. Additional studies are required to investigate specific reasons for the 
large fluctuation in sensitivity in ICP-MS analyses. Additionally, the buffer study 
presented here was for phosphorus. It is believed that this is a representative model to 
predict favorable buffer:solvent compositions for other hard to ionize heteroatoms (S, 
Cl, and F). From the scattered results, it is suggested other studies be performed for
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
76
the specific element of interest. It is apparent that the analytical signal and any 
interferences are specific to the element of interest and would need to be 
characterized for individual atom:buffer:mobile phase combinations.
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CHAPTER 3
EFFECT OF SUPPLEMENTAL NEBULIZER GAS ON ANALYTICAL FIGURES 
OF MERIT FOR USN-MD-ICP-MS DETECTION OF VARIOUS HETEROATOM- 
CONTAINING PHARMACEUTICAL COMPOUNDS
Introduction to Nebulizer Gas Doping Experiments
Argon ICPs have been shown to be effective in supplying a large pool of 
excited state atoms and ions for many elements. However, alternatives to a pure 
argon ICP, such as mixed gas plasmas, have been investigated for several reasons,
f o  zi'y
including: increased tolerance to organic solvent in the matrix * , sensitivity
/ o  / - ' i  n c  c c
enhancements for harder to excite or ionize atoms ’ ‘ , improvements in precision ,
c o  7 7  c o  r t  / ro
reduction of matrix effects ’ , and minimization of spectral interferences ’ ’ .
ICPs derive their bulk physical properties from the carrier gas flows that form and 
sustain the plasma. Argon plasmas will have different properties than helium 
plasmas. The introduction of molecular and atomic gas species into the cool, 
auxiliary, or nebulizer gas flows of an argon plasma has been investigated by 
numerous groups as a means to improve the analytical capabilities of the ICP. The 
most common bleed gases introduced into the argon gas flows are oxygen, nitrogen,
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helium, hydrogen and xenon. The effects of oxygen, nitrogen, and helium gas 
addition to the nebulizer gas flow are detailed in this chapter.
Results from the detection limit, solvent composition and buffer study, 
described previously in this dissertation, provided a basis for additional experiments 
utilizing mixed gas plasmas. Principally, although detection limits for several 
heteroatoms were among the best reported in the literature, any means to lower 
detection limits should be investigated. Secondly, organic solvent loading for 
acetonitrile-containing mobile phases became problematic in ICP-MS experiments. 
Significant carbon deposition on the sample and skimmer cones required increased 
maintenance. The solvent loading on the plasma and increased carbon deposition 
may have also negatively impacted the analytical figures of merit for phosphorus 
detection with organic mobile phase compositions. Finally, the large deviations in 
sensitivity across mobile phase compositions for heteroatom ICP-MS detection 
indicate that HPLC gradient programming is currently not feasible with solvents such 
as acetonitrile. Although it is recognized that other pure or mixed gas excitation and 
ionization sources such as helium MIPs and helium/nitrogen ICPs may be a viable 
route to resolving these issues, the discussion presented here will detail efforts to 
improve sensitivity and organic solvent tolerance utilizing mixed gas argon ICPs.
It was decided that additional experiments investigating nonmetal detection 
would principally involve ICP-MS. ICP-MS detection displayed greater sensitivity, 
has simultaneous multi-element detection capability, and allowed the determination 
of several nonmetal atoms. ICP-MS had detection limits for phosphorus one order of 
magnitude lower than ICP-AES. The monochromator and PMT detector system
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allowed only for single-element detection. Finally, sulfur-, chlorine-, and fluorine- 
containing analytes can not be easily detected with UV-VIS ICP-AES instruments, as 
the most intense atomic line emissions for these elements occur in the wavelength 
region of the spectrum below 190 nm, a region where atmospheric oxygen absorbs 
radiation. Monitoring these emission lines requires a specialized optical path filled 
with nitrogen or argon, or evacuated.
Oxygen Addition to the Nebulizer Gas 
Oxygen addition to an argon plasma is customarily performed when organic
CO
solvents are being nebulized ’ . The presence of oxygen increases the oxidative 
environment of the plasma, allowing for more complete combustion of organic 
solvents. Oxygen-doped plasmas are more resistant to organic solvent loading, 
leading to increased stability of the discharge. Carbon deposition is greatly reduced 
on the sample and skimmer cones in ICP-MS analyses. Oxygen is generally added in
co
small quantities, typically 2-10%, to the auxiliary or nebulizer gas flows . A larger 
fraction of oxygen may be used; however, care must be taken, as high oxygen content 
may cause deterioration of the nickel sample cone. For high oxygen flow rates, 
platinum sample cones may be substituted for the stock nickel cones.
Several groups have studied the effect of adding oxygen to the nebulizer gas 
flow. Goessler and co-workers59 added a 20:80 oxygen:argon mixture to the argon 
nebulizer gas flow for the analysis of phospholipids. They tested several nebulizer 
and supplemental oxygenrargon gas flow rates. It was determined that the signal-to-
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background ratio was not improved with oxygen addition. The additional oxygen 
flow rate decreased the residence time of the aerosol in the spray chamber, reducing 
desolvation. Thus, oxygen addition was not beneficial with this sample introduction 
technique and optimization procedure.
Bjom and Freeh60 introduced 50 mL/min of oxygen into the auxiliary gas flow 
when analyzing solutions containing ethanol and hexane for mercury (m/z = 202), tin 
(m/z = 120), and lead (m/z = 208). This group attempted to add oxygen to the 
nebulizer gas flow but noticed a significant decrease in plasma stability.
Alternatively, oxygen was added to the auxiliary gas flow. Brenner and co-workers61 
characterized a USN-MD sample introduction system for the detection of several 
metal dithiocarbamates in chloroform. The effect of a 30 mL/min of oxygen addition 
to the auxiliary gas on 40Ar12C+ and 40Ar12C1H+ polyatomic interferences of 52Cr+ and 
Cr was characterized. They found a significant decrease in these ion counts.
Carbon deposition on the sample cones was greatly reduced as well.
Cai et al. performed computer simulations on the effect of added oxygen to 
the outer and nebulizer gas flows. These simulations predicted an increase in the 
central channel temperature of an argon-oxygen plasma as compared to a pure argon 
plasma. The predicted increase in temperature suggests additional benefits in the use 
of oxygen as a supplemental gas, namely the reduction of spectral and matrix 
interferences as the formation of polyatomic interferences is inhibited in a hot plasma.
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Nitrogen addition to argon plasmas has been investigated as a means to 
increase sensitivity and decrease spectral and matrix interferences for several atomic
/ o
species. Wang, Evans, and Caruso added 3% nitrogen to the nebulizer gas flow rate 
and noted the elimination of 40Ar35Cl+ and reduction of 35C1160 + , 40A r37Cl+, and 
39Ar2+ polyatomic ions. These cause spectral interferences when determining 75As+,
V , Se , and Se , respectively. A decrease in analyte sensitivities was also 
noted.
Proffock and co-workers69 added nitrogen (0-50 mL/min) to the nebulizer gas 
in an attempt to enhance ionization of phosphorus, sulfur, chlorine, bromine, and 
iodine-containing compounds. A slight increase in sensitivity was shown for several 
analytes, although a large increase in the background for phosphorus had a 
deleterious effect on its detection limit. Addition of greater than 20 mL of nitrogen 
caused a dramatic reduction in ion signals for all species. Enhancement of 
phosphorus signal was also noted by Vonderheide, Meija, Montes-Bayon, and 
Caruso63. The increase in sensitivity was offset by an increase in background ions, 
principally from 15N 160 + and 14N 160 1H+.
Beauchemin and Craig64 added from 0 to 10% nitrogen to the outer gas flow 
and monitored the effect on the analytical signal for several analytes. Also, the effect 
of nitrogen on alleviating ionization suppression from a mobile phase containing 
sodium was studied. Easily ionized elements such as sodium and potassium present 
in the matrix may cause suppression of ionization for other analytes. It was found
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that the addition of 10% nitrogen to the outer gas flow alleviated suppressions of 
12% and 82% for 0.01M and 0.1M sodium-containing solutions, respectively. 
Sensitivity towards other analytes decreased slightly, although the signal-to- 
background ratio improved for iron and selenium, a result of the reduction of spectral 
interferences. A separate study by Holliday and Beauchemin65 also demonstrated a 
reduction in matrix effects upon nitrogen addition to the outer plasma gas. There 
was, however, a concurrent drop in analyte sensitivity.
Other groups have added nitrogen to the auxiliary or coolant gas flows with 
varied results70,71. Discrepancies in results can be attributed to differences in 
instrumental conditions and optimization procedures. Some groups performed 
exhaustive optimization studies. Others groups optimized the system prior to 
supplementary gas addition and minimally altered instrumental settings as the flow of 
nitrogen is increased.
Fundamental studies of nitrogen supplemented argon plasmas indicate that 
nitrogen has a dramatic effect on the bulk properties of the plasma. Sesi et al.72 noted 
a visible widening of the central channel when nitrogen was added to the nebulizer 
gas flow. Measured electron density decreased markedly compared to oxygen and 
helium bleed gases, while decreases in electron and gas-kinetic temperatures were 
also noted. Computer simulations by Mingxiang Cai et al. support these 
experimental findings.
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Helium Addition to the Nebulizer Gas
Supplemental helium addition to argon ICPs has received only modest 
attention, in large part due to the benefits of constructing a pure helium ICP-MS73'77. 
Supplementation or complete replacement of argon as a plasma gas in favor of helium 
is accomplished to increase ionization of harder to ionize elements and contain higher 
energy moieties due to the high ionization energy of helium (24.6 eV) as compared to 
argon (15.8 eV). Helium discharges have been shown to increase the intensity of
7 78nonmetal ion line emissions ’ .
Profrock and co-workers69 found sensitivity enhancements for several 
nonmetal-containing pesticides with the addition of 30 mL/min helium to the
70nebulizer gas flow. Caruso and co-workers observed an increase in sensitivity with 
5% helium added to the nebulizer gas flow for a bromine-containing compound.
f i  7Fundamental studies, performed by Sesi et al. , on the effect of added helium to the 
nebulizer gas flow of argon ICPs indicated a decrease in the electron number density 
in the central region of the plasma. The addition of helium did not significantly alter 
the appearance, shape or density of the plasma, in contrast to the addition of nitrogen. 
The electron temperature did not increase when helium was added to the nebulizer or 
auxiliary gas flows; however, it was found that the gas kinetic temperature increased 
1500 K with the addition of 16.7% helium to either gas flow.
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Considerations for Nebulizer Gas Doping Experiments With USN-MD-
ICP-MS
The addition of oxygen, nitrogen, and helium has not been thoroughly 
characterized for the detection of heteroatoms utilizing an USN-MD sample 
introduction system. Since oxygen is commonly added as a supplementary gas when 
organic matrices are analyzed, a comprehensive examination of the background and 
analytical signal response to increasing amounts of oxygen was performed for 
phosphorus-, sulfur-, chlorine-, and fluorine-containing analytes. Nitrogen and 
helium supplemental nebulizer gas addition is less prevalent as a standard technique 
in ICP-MS analysis. The effect on the background and analytical signal response for 
sulfur- and phosphorus-containing analytes was characterized for nitrogen addition. 
The effect of helium supplementary gas addition was performed for sulfur-containing 
analytes.
Experimental procedures and methods to optimize instrumental settings and 
conditions when supplemental gases are introduced to the argon flow rates is non- 
uniform in the literature. Protocols for oxygen addition supplied with our instrument 
suggest increasing the oxygen flow rate, while nebulizing the organic solvent, until 
the green emission from C2  is not present in the plasma. However, the amount of 
oxygen necessary to significantly reduce the carbon emission will be different 
depending on the type of organic solvent and the composition of the matrix. Also, 
changing the oxygen gas flow rate without adjusting the nebulizer gas flow rate will 
alter the nebulization and transport efficiency, affecting the amount of solvent load on
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the plasma. This could significantly alter the analytical properties of the USN- 
MD-ICP-MS system.
For systematic studies of the effect of supplemental nebulizer gas flows, it 
was decided to maintain the nebulization and transport efficiency. Oxygen 
experiments utilized an oxygen inlet port on the instrument using a calibrated mass 
flow controller. This allowed direct mixing of the oxygen and argon nebulizer gas 
prior to the USN-MD sample introduction system. The combined flow of oxygen and 
argon was maintained at 1.00 L/min to maintain nebulization and transport efficiency.
Nitrogen and helium experiments utilized post USN-MD addition of gas via a 
glass T-junction pictured in Figure 31. The T-junction was connected to the quartz 
torch. The nebulizer gas flow was maintained at 1.00 L/min and helium or nitrogen 
was bled in via a calibrated mass flow controller. This allowed nebulizer and 
transport efficiency to be maintained. However, the total gas flow rate into the 
plasma was altered as the amount of supplementary gas varied. This could have an 
effect on the density of the plasma in the central channel and will change the 
residence time of the analyte and solvent in the plasma. This may change the 
analytical zone of the plasma where the locus of ions is sampled. Several groups re­
optimize the position of the torch relative to the sample cone, termed the sampling 
depth, after adjusting any plasma gas flows. The adjustment of sampling depth is not 
easily reproducible on our instrument and was kept constant as supplemental gas flow 
rates were varied. However, nitrogen and helium studies were carried out over a 
range of forward power levels. Altering the forward power changes the plasma’s 
density and will compensate for reduced residence times by imparting a greater
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Figure 31. Glass T-junction utilized for nitrogen and helium supplementary gas 
studies. Dimensions are 7.0 x 4.0 cm.
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amount of energy to the analyte molecules and solvent. This effectively changes 
the position of the analytical zone of the plasma, hence a comprehensive study of 
analytical and background signals over a range of forward powers will help deduce 
the ability of supplemental gases to enhance the analytical sensitivity of ICP-MS to 
heteroatom-containing compounds.
One final consideration needs to be mentioned concerning the instrumentation 
utilized in this study. Studies conducted prior to the supplementary gas experiments 
used the original r.f. generator and forward powers were typically 800-1400 W for all 
analytes monitored. A refurbished r.f. generator was purchased and installed after the 
original showed signs of failure. A power study was performed utilizing the new r.f. 
generator to determine the background and signal response and optimum forward 
power for the analysis of phosphorus as phosphomycin in aqueous solution. Figures 
32 and 33 illustrate phosphorus signal to background ratios and signal and 
background counts as a function of applied forward power, respectively. Optimum 
forward powers changed significantly to lower power levels than required previously 
for sensitive nonmetal analysis. Above 600 W, there is little or no ion transmission; 
both the phosphorus ion and background signals tend towards zero. The trend is 
observed with other analytes as well. Figure 34 is a mass spectrum obtained at 350 
W for a nebulized solution of 10 ppb strontium (m/z = 87). Figure 35 shows a mass 
scan obtained at 750 W with the same solution being nebulized. No discernible mass 
peaks are present on the same scale as the 350 W mass scan. Visually, at lower 
power levels the plasma is smaller and less dense. When nebulized solvent is 
directed into the plasma, a clear central channel can be distinguished between the
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Figure 32. Graph of signal to background ratio vs. applied forward power for a 100 
ppb solution of phosphorus as phosphomycin.
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Figure 33. Graph of raw signal and background counts vs. applied forward power for 
a 1 0 0  ppb solution of phosphorus as phosphomycin.
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nebulizer gas injector tip and the front of the sample cone. As the power level is 
increased, this central channel diminishes and eventually disappears. These power 
levels are not attainable with standard nebulizers or an USN. The reflected power 
will become too high and the plasma will extinguish. MD is required when operating 
at power levels below 600 W on our instrument.
A thorough review of published literature found no other articles describing 
the utilization of these low power levels in ICP-MS. It is generally accepted that 
lower forward powers produce a plasma that is lower in temperature, less stable, has 
poorer ionization efficiency, and does not tolerate high solvent load. In the context of 
supplemental gas addition, it is important to note that additional gas flows may have 
quite a different effect on the plasma properties at low power levels as compared to 
high power levels typically discussed in literature.
Experimental 
ICP-MS Instrumentation
A Fisons (Thermo Electron) Instruments PlasmaQuad II 27 MHz ICP-MS was 
used. Ion signals from a Burle (Sturbridge, MA) Channeltron 4870V were acquired 
utilizing Thermo Electron PlasmaLab software (Version 1.06.007, Ionflight, Boston, 
MA). The nebulizer gas flow rate was maintained at 1.00 L/min. Supplemental 
oxygen was bled in to form a nebulizer gas composed of 2 , 4 , 6 , 8  and 1 0 % oxygen.
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Helium and nitrogen gases were added as described previously in flow rates of 0- 
80 mL/min. The isotopes monitored for the oxygen doping experiments were 3 5C1+, 
3 1P+, 3 4 S+, and 19F+. During the nitrogen addition experiments 3 1 P+ and 3 4 S+ were 
monitored. In the supplemental helium addition experiments, 3 4 S+ was monitored. A 
weekly routine calibration of the instrument was performed by continuously 
nebulizing a peristaltically pumped 10 ppb solution of Li, Mg, Co, In, Pb, Ce, and U 
in 1% (v/v) nitric acid at a forward power of 1350 W. Tables 13-15 summarize the 
operational parameters used for the oxygen, nitrogen, and helium supplemental gas 
studies.
Reagents and Sample Preparation
An 80 ppm phosphorus-containing stock solution was prepared by dissolving 
an appropriate mass of phosphomycin calcium salt (Sigma-Aldrich, Milwaukee, WI) 
into deionized water. A 50 ppm sulfur-containing stock solution was prepared by 
dissolving an appropriate mass of amoxicillin (Sigma-Aldrich, Milwaukee, WI) in an 
aqueous 0.2% HNO3 solution. A 60 ppm chlorine-containing stock solution was 
prepared by dissolving an appropriate mass of chlorpropamide (Sigma-Alrich, 
Milwaukee, WI) in an aqueous 0.02 M KOH solution. A 500 ppm fluorine-containing 
stock solution was prepared by dissolving ofloxacin (Sigma-Aldrich, Milwaukee, WI) 
in a 4%  NH3 solution. The stock solutions were used to prepare diluted solutions 
with appropriate solvents for analyses. HPLC grade methanol and acetonitrile 
(Sigma-Aldrich, Milwaukee, WI) and 18 M£>cm deionized water were used for
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Table 13. Operating parameters for oxygen addition experiments.
Sample introduction system
Peristaltic pump flow rate, mL/min 1.0
Nebulizer gas flow rate, L/min 1.0
Oxygen gas flow rate, mL/min 20-100
Nebulizer heater temperature, °C 140
Nebulizer condenser temperature, °C 3
Membrane desolvator temperature, °C 160
Membrane desolvator countercurrent flow rate, L/min 1.5
ICP-MS system
Optimal RF power, W 490 (P, S); 510 (Cl, F);
Detector Burle Channeltron 4870V
Outer gas flow rate, L/min 14.0
Intermediate gas flow rate, L/min 0.8
Data acquisition parameters
Scan mode Single ion monitor
Dwell time, ms 250
Isotopes monitored 31P, 34S, 35C1, 19f
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Table 14. Operating parameters for nitrogen addition experiments.
Sample introduction system
Peristaltic pump flow rate, mL/min 1.0
Nebulizer gas flow rate, L/min 1.0
Nitrogen gas flow rate, mL/min 10-70
Nebulizer heater temperature, °C 140
Nebulizer condenser temperature, °C 3
Membrane desolvator temperature, °C 160
Membrane desolvator countercurrent flow rate, L/min 1.5
ICP-MS system
Optimal RF power, W 450-1350 (P, S)
Detector Burle Channeltron 4870V
Outer gas flow rate, L/min 14.0
Intermediate gas flow rate, L/min 0.8
Data acquisition parameters
Scan mode
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Table 15. Operating parameters for helium addition experiments.
Sample introduction system
96
Peristaltic pump flow rate, mL/min 1.0
Nebulizer gas flow rate, L/min 1.0
Helium gas flow rate, mL/min 10-80
Nebulizer heater temperature, °C 140
Nebulizer condenser temperature, °C 3
Membrane desolvator temperature, °C 160
Membrane desolvator countercurrent flow rate, L/min 2.2
ICP-MS system
Optimal RF power, W 450-590
Detector Burle Channeltron 4870V
Outer gas flow rate, L/min 14.0
Intermediate gas flow rate, L/min 0.8
Data acquisition parameters
Scan mode Single ion monitor
Dwell time, ms 250
Isotope monitored 34S
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sample preparation. The structures of analytes used in this study can be found in 
Figure 10.
Results and Discussion for Oxygen Addition 
Data for Oxygen Addition
The effects of oxygen addition were observed for pure aqueous, 50:50 
methanohaqueous (MeOHiaqueous), and 50:50 acetonitrile:aqueous (ACN:aqueous) 
solvent compositions. Tables 16-19 contain the results of oxygen addition for sulfur-, 
phosphorus-, chlorine-, and fluorine-containing analytes. Figures 36-47 contain plots 
of effects of oxygen addition on sensitivities, background signal intensities, and 
detection limits for all analytes.
Physical Characteristics of an Oxygen Doped ICP
The addition of oxygen had a visibly noticeable effect on the size, shape, and 
density of plasma. The central channel appeared to constrict with addition of oxygen 
to the nebulizer gas. The density of the plasma slightly increased near the sample 
cone and slightly decreased near the nebulizer injector tube from the torch. These 
changes may indicate a shift of the analytical zone of the plasma. Fluctuations in 
analytical and background signals may be due to such a shift. When operating at
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0 1000 3.5 77 21
2 1000 5.3 78 22
4 1000 5.1 100 15
6 1000 5.3 120 18
8 1000 8.2 150 23












0 1000 1.7 110 11
2 1000 1.9 100 13
4 1000 1.7 83 14
6 1000 1.3 70 14
8 1000 1.0 62 14












0 1000 2.2 120 12
2 1000 3.3 110 15
4 1000 3.0 85 21
6 1000 2.1 86 18
8 1000 1.7 72 15
10 1000 1.1 50 17
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
99











0 40 0.1 7.2 2.4
2 40 3.4 5.5 11
4 40 2.8 7.2 6.1
6 40 2.9 8.5 5.3
8 40 2.1 11 3.8












0 40 0.5 3.4 4.3
2 40 0.6 3.4 4.7
4 40 0.7 1.7 6.9
6 40 0.6 2.1 6.5
8 40 0.6 1.9 5.7












0 4000 3.1 680 4.3
2 4000 2.1 860 2.4
4 4000 3.9 820 5.3
6 4000 3.3 750 4.5
8 4000 2.9 680 4.9
10 4000 1.3 570 2.8
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0 1200 0.3 34 9.3
2 1200 0.3 31 9.1
4 1200 0.6 28 18
6 1200 1.0 25 28
8 1200 1.4 25 32












0 6000 1.5 250 6.2
2 6000 1.5 170 8.8
4 6000 1.5 210 7.5
6 6000 1.5 180 11
8 6000 1.5 160 14












0 1200 3.2 4.2 19
2 1200 7.2 3.6 30
4 1200 7.0 2.8 28
6 1200 6.2 2.6 23
8 1200 7.8 1.6 25
10 1200 8.8 ND 27
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0 20 1.2 4.2 2.1
2 20 1.1 3.6 2.0
4 20 1.5 2.8 3.1
6 20 1.9 2.6 4.4
8 20 2.6 1.6 11












0 20 4.4 3.5 5.5
2 20 4.8 2.9 4.6
4 20 6.2 3.6 4.3
6 20 6.6 4.6 3.7
8 20 7.7 3.5 5.7












0 100 4.9 2.7 18
2 100 4.9 2.6 19
4 100 4.9 4.1 12
6 100 6.2 3.3 16
8 100 7.8 2.8 23
10 100 8.8 3.6 21
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Normalized Sulfur Signal For Various Amounts 
of Oxygen
♦ —Aqueous 
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Figure 36. Analytical signal trends for sulfur as a function of oxygen nebulizer gas 
composition. Signal has been normalized to a value of 100 with respect to the signal
seen with 0% added.
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of Oxygen
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Figure 37. Background signal intensity for sulfur as a function of oxygen nebulizer
gas composition.
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Figure 38. Detection limits for sulfur as a function of oxygen nebulizer gas
composition.
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Figure 39. Analytical signal trends for phosphorus as a function of oxygen nebulizer 
gas composition. Signal has been normalized to a value of 100 with respect to the
signal seen with 0% added.
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Figure 40. Background signal intensity for phosphorus as a function of oxygen
nebulizer gas composition.
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Figure 41. Detection limits for phosphorus as a function of oxygen nebulizer gas
composition.
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Figure 42. Analytical signal trends for chlorine as a function of oxygen nebulizer gas 
composition. Signal has been normalized to a value of 100 with respect to the signal
seen with 0% added.
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Figure 43. Background signal intensity for chlorine as a function of oxygen nebulizer
gas composition.
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Figure 44. Detection limits for chlorine as a function of oxygen nebulizer gas
composition.
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Figure 45. Analytical signal trends for fluorine as a function of oxygen nebulizer gas 
composition. Signal has been normalized to a value of 100 with respect to the signal
seen with 0% added.
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Figure 46. Background signal intensity for fluorine as a function of oxygen nebulizer
gas composition.
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Figure 47. Detection limits for fluorine as a function of oxygen nebulizer gas
composition.
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standard ICP forward powers (greater than 1 kW), the addition of oxygen gas 
does not yield noticeable changes in the plasma. Consequently, several groups do not 
optimize any instrumental parameters when oxygen is bled into the nebulizer gas 
flow. As noted previously, optimization procedures vary for bleed gas experiments. 
Optimization procedures performed in this experiment involved maximizing the S/B 
ratio for aqueous solutions. All other conditions were kept the same as oxygen was 
added.
The introduction of organic solvent produced a light green C2  emission 
signaling solvent load on the plasma. This was more pronounced with the ACN:H20 
solution. Membrane desolvation allowed the plasma to maintain its stability. Green 
emission was not observed in the buffer study where the plasma forward powers were 
higher than in this study. Membrane desolvator countercurrent flow rates were 
increased and nebulizer flow rates were decreased in an attempt to alleviate the 
solvent load. Changing these parameters lessened the intensity of the emission, but 
had a negative impact on the background and analyte signal. It was decided to 
maintain optimal settings for the aqueous solution.
Minimum Oxygen Flow Rate for Effective Carbon Removal
Using increasing amounts of oxygen may decrease the amount of system 
maintenance, but may cause performance sacrifices to be necessary. With no oxygen, 
a 50% acetonitrile solution was nebulized until some carbon deposition was noted on 
the sample cone. Oxygen was then introduced into the nebulizer gas in increasing
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volume flow rates until the carbon on the cone was removed. This established a 
lower limit of 6% oxygen required to remove carbon building up on the sample cone 
faster than it was being deposited.
Interferences in Oxygen Addition Experiments
Table 20 lists the potential atomic and polyatomic interferences present at the 
nominal m/z values of the analytes monitored in this study. The table differentiates 
between interferences that are most problematic and ones less likely to be present in 
appreciable amounts. For example, due to the low natural abundances of 180  and 13C,
13 18 ■)-interferences at m/z = 31 from C O are expected to be much less than 
interferences from 15N 160 +. For this study, it would be expected that an analyte with 
an oxygen-, carbon-, or argon-containing interferent would have a greater likelihood 
of producing an interference.
Another interference effect arises from the possibility of the formation of 
molecular analyte species. For instance, oxides of the analyte may be formed. Mass 
spectral scans were obtained for all solvent compositions with different percentages 
of oxygen added. Special attention was paid to potential oxides of sulfur, phosphorus 
and chlorine. An example mass spectral scan of 32S160 + at m/z 48 is shown in Figure 
48. A peak appeared after nebulization of a 1000 ppb sulfur solution. Figure 49 is a 
mass spectral scan taken with an aqueous background solution and a 100 ppb solution 
of phosphorus. The appearance of a peak at m/z 48 indicates the formation of
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More Likely Less Likely
Element Isotope Abundance Interferences Interferences
Phosphorus P 100% 15n 16o , ' W h 13C i80 ,12C180 ‘H,
15N2!H
Sulfur 32S 95.02% 16o 16o 15n 16o 1h , 14n 18o
34s 4.67% none ^ H ,  15N 18OlH
36s 0.02% 36Ar
Chlorine 35C1 75.77% none 160 i«0 ih>
37C1 24.23% 36Ar *H, ^S 'H
Fluorine 19f 100% 160 1H3.38Ai^ 18o ‘h
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Signal (cps)
48.548,2 48.3 48.448.0 48.147.8 47.847.747.6
m/z
Figure 48. Mass spectrum of the m/z = 48 ion for a 1000 ppb sulfur solution of 
50:50 (ACN:Aqueous): 10% oxygen (blue) and 4% oxygen (black). 
Background counts with no sulfur analyte were negligible.
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Figure 49. Mass spectrum of aqueous background (black) and a 100 ppb solution of 
phosphorus as phosphomycin (blue). Note the peak at m/z 48.
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31P160 1H+. Subsequent mass scans were performed with various oxygen addition 
amounts to attempt to elucidate whether oxide interferences were enhanced or 
mitigated with oxygen addition. Signal intensity at the oxide masses displayed 
variable changes with the addition of oxygen and were of low intensity, making 
determination of the formation of oxide species difficult. It is probable that oxide 
species are formed for sulfur- and phosphorus-containing analytes in limited 
quantities with small additions of oxygen to the nebulizer gas. No oxide species were 
noted for chlorine- or fluorine-containing analytes.
Oxygen Addition: Sulfur Results
Sulfur was monitored as the 34S+ isotope in preference to the 32S+ isotope, 
which has a significant 1602+ interference (Table 20). Observing the average 
analytical signal for methanol and acetonitrile in Table 16 and Figure 36, it is shown 
that there is a decrease in sensitivity as the amount of oxygen in the nebulizer gas is 
increased. Analytical signals for both methanol and acetonitrile solutions were 
suppressed by greater than 50% with 10% added oxygen. The analytical signal 
response in the pure aqueous solution for sulfur was markedly different than in the 
organic solutions. Instead of a signal decrease with increasing flow of oxygen, the 
analytical signal was enhanced. With 10% added oxygen, the analytical signal was 
enhanced by over a factor of 2.
Figure 37 and Table 16 illustrate the effect oxygen addition had on the 
background signal intensity for all solutions. Interestingly, trends are similar to those
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observed for the analytical sensitivities. The background signal intensity for both 
organic solvent compositions decreased with increasing amounts of oxygen added. 
The background intensity dropped by a factor of 2 with 10% oxygen added. The 
aqueous solvent background signal increased with increasing percentages of oxygen 
added to the nebulizer gas flow. With 10% added oxygen, the background signal was 
increased by over a factor of 2.
Figure 38 and Table 16 show the detection limit trends for all solvent 
compositions. All three solvent compositions display variability in detection limits 
across the oxygen flow rate range. Neither large improvements nor degradations in 
detection limits were observed. For the organic solvent compositions, detection 
limits deteriorated marginally (< 50%) from initial conditions with no oxygen added 
to 10% oxygen in the nebulizer gas flow. For the aqueous solution, there was not a 
statistically significant change in the detection limit.
The analytical and background signal trends observed with sulfur analytes are 
likely due to subtle shifts in the analytical zone with respect to the ion sampling cone 
as oxygen gas is added to the nebulizer gas flow. While the total gas flow rate is held 
constant, the oxygen gas added will affect the macroscopic properties of the argon 
plasma. The graphs illustrating sensitivity and background signal trends as a function 
of oxygen in the nebulizer gas are similar. This indicates a loss or increase of both 
analyte and background ions with increasing oxygen content for solvent 
compositions. There was an increase in both the analytical signal and background for 
the pure aqueous solvent.
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The S/B for all the solvent compositions were relatively stable. For the 
pure aqueous solution, the average S/B for all flow rates was approximately 19 with a 
relative standard deviation of 14%. MeOHrFbO had an average S/B of 56 with a 
relative standard deviation of 10%. Finally, the ACN:H20 solvent had an average 
S/B of 40 with a relative standard deviation of 20%. It is apparent from these results 
that there is neither significant ionization enhancement nor depression for sulfur with 
oxygen addition. Furthermore, there is not a large increase in background from 
polyatomic interferences. The main interferents for 34S+ (Table 20) contain low 
natural abundance oxygen atoms. Addition of oxygen or the nebulization of organic 
solvent would not be expected to appreciably increase the background ion counts at 
34S+.
Oxygen Addition: Phosphorus Results
Phosphorus was monitored as the P isotope. Table 17 and Figure 39 
illustrate a loss in analytical signal and sensitivity with increasing amounts of oxygen 
for both Me0H:H20 and ACFhtkO solvents. The analytical signal increased for the 
pure aqueous solvent exhibiting behavior similar to the sulfur analyte.
Figure 40 and Table 17 display the background signal trend at m/z = 31 for all 
solvent compositions. There are several points to note. First, the background 
increased dramatically when oxygen was introduced for the aqueous solutions. 
Second, background ion counts for the MeOH:H20 solution are not significantly 
affected by the presence of oxygen in the nebulizer gas. Finally, the addition of
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oxygen yielded a variable response of the background ion count for the ACN:H2 0  
solvent.
Figure 41 shows the detection limit trends for phosphorus as a function of 
added oxygen for each solvent composition. With the exception of a repeatable spike 
in the detection limit at 2%  oxygen, detection limits remained low for all solvent 
compositions and oxygen flow rates. The best detection limits for the pure aqueous 
and MeOFktbO solution occur with no oxygen added to the nebulizer gas flow. The 
detection limit as a function of oxygen flow rate was variable for the ACNrF^O 
solution. The best detection limit was obtained at 2% added oxygen.
Similar to sulfur, responses in the analytical and background signal for 
phosphorus as a function of added oxygen are likely affected by shifts in the 
analytical zone of the plasma. However, the data also indicates significantly different 
behavior with respect to the S/B ratio for the pure aqueous solvent. With no oxygen 
added, the S/B ratio is found to be 72. Introducing 2% oxygen lowered this ratio to 
1.6. The background signal rose by over a factor of 34 without a corresponding 
elevation in the analytical signal. This likely indicates that additional interfering ions 
such as 14N 160 !H+ (Table 20) are being formed and/or sampled when oxygen is 
entrained in the nebulizer gas. The analytical signal decreases when 2%  oxygen is 
added to the nebulizer gas flow. This suggests either that the production of 31P+ is 
being suppressed or the analytical zone is shifted so that a region of the central 
channel with a lower ion number density is being sampled. A further possibility is 
that phosphorus oxide species are being formed in small quantities, reducing the 
production of 31P+. As noted previously, mass spectral scans were obtained at various
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oxygen flow rates. These scans indicated the presence of ions at the 31P160 1H+. 
Deducing whether added oxygen mitigates or enhances the formation of this ion is 
difficult. This is due to its low intensity and the variability in ion signals as the 
analytical zone of the plasma shifts with increasing amounts of added oxygen.
With aqueous solutions, as the amount of added oxygen is increased, the 
analytical signal recovers and is slightly enhanced with 8% or greater oxygen added. 
The S/B ratio is variable from 1.6 to a maximum of 5.2 with 8% oxygen added. From 
the data, it is unclear what is causing the enhancement of ionization. It is possible 
that the higher thermal temperatures predicted with oxygen addition may enhance the 
ionization of phosphorus atoms. The higher thermal energy may mitigate the 
formation of polyatomic phosphorus species. It may also be that the analytical zone 
shifts with increasing amounts of oxygen so that the relative number of phosphorus 
ions sampled is larger than the number of background ions.
For the Me0H:H20 solution, the background ion signal is relatively constant 
as the amount of added oxygen is increased. Added oxygen may be consumed to an 
extent where it is not causing large increases in the background ion count as in 
aqueous solvents. The analytical signal generally decreases as the amount of oxygen 
added increases, indicating either ionization suppression or that fewer phosphorus 
ions are being sampled due to slight shifts in the analytical zone.
For ACNrFhO solutions, a consistent trend in background or analyte signal 
was not apparent. S/B ratios fluctuated considerably as well. Due to its lower 
volatility and increased carbon content relative to methanol, ACN will have a larger 
effect on the plasma. It will not be as easily oxidized as methanol and will require
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larger flow rates of oxygen to mitigate its deleterious effects on the plasma. In 
addition, background interferences from nitrogen-containing species may be more 
problematic (Table 20) ACN. The fluctuations in signal for both the background and 
analytical signal are likely due to these factors as well as subtle shifts in the analytical 
zone of the plasma.
Oxygen Addition: Chlorine Results 
As it is the most abundant isotope and relatively free from interferences,
35 "bchlorine was monitored as the Cl isotope. For all solvent compositions, Table 18 
and Figure 42 show trends of decreasing analytical signals with increasing oxygen 
flow rates. The depression was greatest for the MeOFFFbO solution. Signal loss was 
least with the ACNrFbO solution.
Figure 43 and Table 18 present the background signal trends as a function of 
added oxygen. The background ion intensity for ACNrFbO and pure aqueous 
solutions increases the most. The background ion intensity for the MeOFFFkO 
remained essentially constant for all oxygen flow rates up to 8%. With 10% oxygen 
the background intensity also increased.
Figure 44 and Table 18 show the detection limit trends as a function of added 
oxygen. The best detection limits for all solvent compositions were obtained when no 
oxygen was added to the nebulizer gas flow. Deterioration in the detection limits was 
noted for all three solvent compositions. The pure aqueous solvent displayed the
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most dramatic rise in detection limits, increasing by over a factor of 3 when going 
from 0% oxygen to 10% added oxygen.
The S/B ratio decreases for all three solvent compositions. The increase in 
background intensity for the pure aqueous and the ACN:aqueous solvents is likely 
due to the formation of 160 I80 1Hf polyatomic ions and a shifting of the analytical 
zone of the plasma so that an increased number of background ions are sampled. The 
MeOHitbO background intensity did not increase proportionally, suggesting that the 
spatial distribution of background ions in the plasma is different than both the 
aqueous and ACN:H2 0  solvents.
Analytical signal trends are consistent for all three solvent compositions. 
Signal decreases are likely due to a combination of three factors. The analytical zone 
is shifting, potentially reducing the number of ionized chlorine atoms sampled by the 
mass spectrometer. Chlorine oxides may be forming, although there is no direct mass 
spectral data that indicates this. Finally, as described previously, the plasma becomes 
less dense in the central channel and is shifted away from the injector tube. Hence 
the residence times of analyte atoms may not be as long. This would cause a decrease 
in analytical signal, especially for harder-to-ionize elements. The analytical signal for 
chlorine in the pure aqueous solvent is depressed as the flow rate of oxygen is 
increased. This breaks a trend established from sulfur and phosphorus results. Both 
phosphorus and sulfur displayed an increase in analytical signal with increased 
oxygen addition. It should be noted that the ionization energy for chlorine (13.01 eV) 
is greater than that of either sulfur (10.98 eV) or phosphorus (10.48 eV). The effect
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of the ionizing power of the ICP with added oxygen may play a role in more 
greatly affecting chlorine ionization.
Oxygen Addition: Fluorine Results
Monoisotopic fluorine was monitored at m/z = 19. Table 19 and Figure 45 
display the analytical signal trends for fluorine as a function of oxygen added to the 
nebulizer gas flow. With the pure aqueous solution there is a significant decrease in 
the fluorine analytical signal as the amount of oxygen is increased. At 10% oxygen, 
the fluorine ion signal is not visible above the background noise. In contrast, the 
analytical signals for the organic solutions fluctuate and are enhanced at some oxygen 
flow rates.
Table 19 and Figure 46 show the background signal trends for fluorine. All 
three solvent compositions exhibited a rise in the background ion signal with 
increasing amounts of added oxygen. The rise in background signal is likely due to 
the highly interfering oxygen-containing polyatomic ions (Table 20) formed in 
greater quantities as increasing amounts of oxygen are added.
Detection limits trends are displayed in Figure 47 and Table 19. For each 
solvent composition, detection limits became worse as the amount of added oxygen 
was increased. At 10% oxygen, the detection limit for fluorine in the aqueous 
solution could not be calculated. Detection limits for the AChhFfcO solution were 
scattered and also greater than with the MeOHrFhO and pure aqueous solutions.
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As stated previously, the rise in background signal for all solutions is 
likely due to an increased amount of 160 1H3+ polyatomic ions interfering at m/z=19. 
For the pure aqueous solvent, the decrease in analytical signal may be due to poorer 
high energy ionization characteristics of the plasma. For the organic solvent 
compositions, the analytical signal did not decrease as it had for most other analytes. 
One possible explanation is that the other analytes are forming polyatomic oxide ions 
with the entrained oxygen while fluorine is not. Fluorine is much less likely to form 
bonds with oxygen than sulfur, phosphorus, and chlorine. Further experimentation is 
necessary to draw any conclusions from these results.
Oxygen Study Conclusions
The analytical and background responses for four nonmetal-containing 
analytes in aqueous, MeOFFFkO, and AGShF^O solutions with addition of oxygen 
has been demonstrated across the working range of oxygen flow rates. In general, 
degradations in sulfur, phosphorus, and chlorine analytical signals are observed as the 
percentage of oxygen bled into the nebulizer gas is increased. As the percentage of 
oxygen is increased, the fluorine signal displayed signal intensity scatter in the 
organic solutions. With pure aqueous solutions, sulfur and phosphorus analytes 
display an increase in sensitivity with increasing plasma oxygen content. Chlorine- 
and fluorine-containing analytes display a decrease in aqueous solutions as the 
oxygen content is increased. Signal degradation may be due to ionization 
interference effects and subtle shifts of the analytical zone of the plasma. Further
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studies and simulations are necessary to deduce any differences between plasma 
behavior and temperature in this system (<500W) as compared to previous studies 
(>800W). These results indicate that moderate amounts of oxygen may be added to 
the nebulizer gas without a large overall increase in detection limits while obtaining 
the benefit of carbon removal and sample cone lifetime.
Additional experiments to further understand the observed plasma behavior 
would include performing oxygen addition after the sample stream passed through the 
membrane desolvator. Power levels would be varied to ascertain the best conditions 
for both organic solvent pyrolysis and sensitive nonmetal determinations. 
Supplemental oxygen gas flows to the auxiliary or cool gas flows could be 
investigated as well. Finally, a second set of optimization procedures, such as 
maximizing the analytical signal after each oxygen addition by changing the plasma 
forward power or the torch sampling depth, would aid in defining the optimal oxygen 
addition conditions.
Results and Discussion for Nitrogen Addition 
Introduction
Nitrogen addition to the nebulizer gas flow was investigated in an effort to 
improve nonmetal detection limits. As previously discussed, sensitivity 
enhancements have been noted for a number of metal and nonmetal-containing 
analytes. However, the literature contains conflicting results. The mechanism for
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sensitivity enhancement is not well understood. Previous research indicates a 
reduction of polyatomic interferences yielding lower backgrounds and higher 
analytical signals. It has also been found that nitrogen addition to the outer gas of an 
argon plasma boosts plasma temperatures resulting in more efficient ionization. The 
addition of nitrogen to the nebulizer gas, however, is expected to lower the 
temperature in the central channel of the plasma69. The effects of nitrogen upon 
nonmetal determinations with USN-MD sample introduction has not been 
investigated thoroughly.
The study presented in this dissertation is intended to examine trends for 
nonmetal analytical response for small additions of nitrogen to the nebulizer gas flow. 
Phosphorus and sulfur were the nonmetal elements studied in these experiments. 
Nebulization and transport efficiencies were held constant with a fixed nebulizer gas 
flow of 1.00 L/min. Nitrogen gas was added following sample introduction, 
immediately before the quartz torch by attachment of the previously described glass 
T-junction (Figure 31). Nitrogen was bled in at flow rates ranging from 0-70 
mL/min. System optimization was performed by maximizing the analytical signal for 
an aqueous solution containing phosphorus or sulfur analytes. Sampling was held 
constant and flow rates were tested at forward powers between 450-1350 W in 
increments of 100 W. Mass spectral scans were obtained for background and analyte- 
containing solutions.
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Physical Properties of a Nitrogen Doped ICP
Similar to the addition of oxygen, nitrogen addition had a noticeable effect on 
the size, shape, and density of plasma. However, these effects were more 
pronounced and affected the stability of the plasma. At the lower forward powers, the 
ICP could not tolerate high nitrogen flow rates due to high reflected power levels.
The r.f. generator has an interlock that automatically extinguishes the plasma at high 
reflected powers. Table 21 lists the attainable nitrogen volume flow rates at the 
power levels studied in these experiments. Visible effects of added nitrogen on the 
plasma were different and more significant than in oxygen addition experiments.
The central channel widened and appeared less intense from the torch injector to the 
sample cone. The plasma shifted away from the torch injector and shrank 
considerably. In contrast to oxygen addition, noticeable changes in the plasma 
remained when operating at standard forward powers (greater than 1 kW), although 
they diminished with increasing forward powers. The analytical zone of the plasma 
shifts with nitrogen addition and is expected to cause larger fluctuations in the 
analytical and background signals.
Interferences in Nitrogen Addition Experiments
Table 20 lists the interferences expected for phosphorus and sulfur. Strong 
nitrogen-containing interferences (15N I60 +, are present at the phosphorus
ion mass. The mass = 34 ion,34S+, also contains a nitrogen-based interferent
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Table 21. Tolerable nitrogen flow rates at forward powers utilized. 





850 Full Range (0-70)
950 Full Range (0-70)
1050 Full Range (0-70)
1150 Full Range (0-70)
1250 Full Range (0-70)
1350 Full Range (0-70)
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(15N180 1H+). This interferent is expected to be less problematic due to the low 
natural abundances of 180  and 15N (Table 20). Additionally, experimental results79 
and computer simulations69 predict a decrease in the temperature of the plasma when 
nitrogen is added to the nebulizer gas flow. This may contribute to increased 
background ion counts, as reduced plasma temperatures allow the formation of 
polyatomic interferences in an argon ICP.
Similar to the oxygen doping experiments, phosphorus and sulfur have the 
potential to form oxides, leading to monoatomic analyte ion reductions. As noted 
previously, Figures 48 and 49 indicate the formation of sulfur and phosphorus oxides. 
Subsequent mass spectral scans, obtained with increasing flow rates of nitrogen, 
cause these ion peak intensities to diminish. However, it is unclear whether nitrogen 
is eliminating oxide formation or there is a reduction in the number of ions sampled 
by the mass spectrometer. Other ion signal intensities, including those of the analyte, 
also decreased.
Nitrogen Addition: Phosphorus Results
Phosphorus was monitored at 31P+. Figures 50-59 exhibit the analytical and 
background signals as a function of nitrogen flow rate for all powers tested.
Although the absolute intensity for the signal and background is not directly 
comparable between forward powers because they were run on different days, the y- 
axis range was held constant to give a relative indication of which power levels 
yielded higher ion counts. Results are not reported for some nitrogen flow rates due
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Figure 50. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 450 watts.
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Figure 51. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 550 watts.
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Figure 52. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 650 watts.
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Figure 53. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 750 watts.
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Figure 54. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 850 watts.
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Figure 55. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 950 watts.
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Figure 56. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 1050 watts.
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Forward Power = 1150 W
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Figure 57. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 1150 watts.
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Figure 58. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power o f 1250 watts.
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Figure 59. Plot of analytical (♦) and background (■) signals for phosphorus at an 
applied forward power of 1350 watts.
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to low count rates or plasma extinguishment due to high reflected powers. For 
example, Figure 53 displays no data for 0, 60, and 70 mL/min of nitrogen added. 
Count rates for the background and analyte signals were nearly identical and low 
(<20 cps) with no added nitrogen. The high reflected forward power made the 
plasma system inoperable with 60 mL/min or more of added nitrogen.
Figures 50-59 show that there is a narrow range of nitrogen flow rates that 
yields a sensitive analytical signal. At low forward powers, there are maxima in the 
analytical signals at discrete nitrogen flow rates. These maxima appear at 10 (650 
and 750 W) and 20 mL/min (850 W) of added nitrogen. All other nitrogen flow rates 
yield extremely low analytical signals. As the forward power levels are increased to 
the range of 1000 W (Figures 55 and 56), a wider window of nitrogen flow rates yield 
a measurable analytical signal. The largest signals occurred under the initial starting 
conditions (450 W and no added nitrogen) and with 20 mL/min of nitrogen at 850 W.
Figure 60 illustrates a plot of the flow rate o f nitrogen that yields the largest 
analytical signal at each power. The graph clearly indicates that increasing flow rates 
of nitrogen are necessary to obtain the highest analytical signals as the forward power 
increases. In Figure 61 the maximum analytical signal obtained is plotted as a 
function of forward power. The graph indicates a depression in analytical signal as 
the forward power is increased from 450 to 550 W. At higher powers (650 to 1350 
W), the signal exhibits a maximum at 850 W.
The right y-axes correspond to background signal intensities in Figures 50-59. 
The background signals display trends similar to those of the analytical signals. At
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Figure 60. Plot of nitrogen flow rate that yields the largest analytical signal at all
forward powers.
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Figure 61. Plot of maximum analytical signal observed for all forward powers.
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lower forward powers, 450 to 850 W, the background signals reach a maximum at 
one nitrogen flow rate relative to other flow rates (Figures 50-54). The flow rate 
range of the signal enhancement is small. At higher forward powers, 950 to 1150 W, 
a wider range of nitrogen flow rates produces a noticeable increase in the background 
signals (Figures 55-57). At the highest forward powers, 1250 and 1350 W, both 
background and analytical signals are depressed (Figures 58 and 59). A wide range 
of nitrogen flow rates yielded similar background signals. The largest background 
signal occurred at a forward power of 850 W with 20 mL/min of nitrogen added to 
the nebulizer gas flow. In all cases, it is likely that polyatomic species such as 
14N 16o 'H+ and 15N 160 + (Table 20) are contributing to the increase in the background 
signal.
Figure 62 depicts the flow rate of nitrogen that yields the highest background 
signal as a function of applied power. In general, the background increases as the 
forward power is increased. This may indicate that higher forward powers facilitate 
background ion formation due to the increased thermal energy of the plasma. 
Increasing the amount of nitrogen may lower the central channel temperature, 
allowing more favorable reaction conditions for polyatomic ion formation. Figure 63 
shows the maximum background signal as a function of applied forward power. The 
highest background signal is obtained at a nitrogen flow rate of 20 mL/min at a 
forward power of 850 W. At this point, conditions favor a combination of 
background ion formation and sampling.
Figure 64 displays the S/B ratios for all forward power levels and nitrogen 
flow rates tested. The highest S/B ratio is found at 450 W with no added nitrogen.
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Figure 62. Plot of nitrogen flow rate that yields the largest background signal at all
forward powers.
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Figure 63. Plot of maximum background signal observed for all forward powers.
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Figure 64. Surface contour displaying S/B trends for phosphorus against applied 
power and nitrogen flow rate added to the nebulizer gas.
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With nitrogen addition, the highest S/B ratio is at 1050 W with 10 mL/min of 
nitrogen added. In general, the S/B ratio was depressed with increasing flow rates of 
nitrogen.
Table 22 lists the nitrogen flow rate that yielded the lowest detection limit for 
every forward power. Detection limits, with few exceptions, did not demonstrate 
significant enhancement or deterioration from nitrogen addition. The lowest 
detection limit achieved was 3 ppb P. This value was attained at 450 W with no 
addition of nitrogen and at 850 W with 10 mL/min of nitrogen added. A number of 
the conditions tested had detection limits for phosphorus in the single ppb range.
Some conclusions may be drawn from the results and observations noted in 
these studies. It appears that there is a reduction in ionization and/or an increase in 
background intensity leading to a reduction in the S/B ratio for 31P+ when nitrogen is 
added to the nebulizer gas flow. At 450 W and no nitrogen added, the S/B ratio is 
greatest with a value of 43. All other instrumental conditions yielded S/B levels 
reduced by greater than 50%. Comparing the analytical and background signals at 
low and high power, there appears to be a greater number of analyte and background 
ions within the plasma at higher forward powers. The addition of nitrogen will shift 
the analytical zone of the plasma, causing a change in both the background and 
analytical signal. Also, the net background signal is greater with the addition of 
nitrogen. The results indicate increased reaction chemistry within the plasma that 
leads to higher levels of nitrogen-containing polyatomic ions. At low power levels, 
the small flow rate range of the enhancement in background and analytical signals 
indicates that the optimum sampling region is critically sensitive to changes in plasma
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Table 22. Table o f nitrogen flow rates yielding the lowest detection limit for 
phosphorus at each forward power utilized.
Forward Power Detection Limit S/B Ratio Nitrogen Flow
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conditions. That this flow rate range becomes larger at higher power levels 
indicates an increase in the size of the useful analytical sampling zone.
Nitrogen Addition: Sulfur Results
Sulfur was monitored at 34S+. Figures 65-70 illustrate the analytical and 
background signals as a function of nitrogen flow rate for forward powers of 450 to 
1350 W. At lower forward powers (Figures 65 and 66), 450 to 550 W, there are 
narrow ranges of nitrogen flow rates at which significant analytical signals are seen. 
As the forward powers are increased above 750 W, a greater range of nitrogen flow 
rates yields measurable analytical signals (Figures 67 and 68). This behavior 
parallels trends seen in the phosphorus experiments. However, at the highest forward 
power levels, at 1250 and 1350 W (Figures 69 and 70), there is a trend of small 
nitrogen flow rate ranges yielding large analytical signals.
Figure 71 depicts the nitrogen flow rate that yields the greatest analytical 
signal for all forward powers. Similar to the phosphorus experiments, there is a 
general trend of increasing nitrogen flow rate for maximum signal with increasing 
forward power. However, at 1150 W and above 1250 W, there is a notable decrease 
in the nitrogen flow rate yielding the maximum analytical signal.
In Figure 72, the maximum analytical signal obtained at each power level is 
plotted. The maximum signal is seen at 450 W. There is a substantial decrease in the 
analytical signal as the plasma power is increased. At 450 W, the addition of nitrogen 
appears to either quench the formation of sulfur ions or shift the analytical zone of the
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Figure 65. Plot of analytical (♦) and background (■) signals at an applied forward
power of 450 watts.
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Figure 66. Plot of analytical (♦) and background (■) signals at an applied forward
power of 550 watts.
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Figure 67. Plot of analytical (♦) and background (■) signals at an applied forward
power of 750 watts.
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Figure 68. Plot of analytical (♦) and background (■) signals at an applied forward
power of 1050 watts.
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Figure 69. Plot of analytical (♦) and background (■) signals at an applied forward
power of 1250 watts.
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Figure 70. Plot of analytical (♦) and background (■) signals at an applied forward
power of 1350 watts.
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Figure 71. Plot of nitrogen flow rate that yields the largest analytical signal at all
forward powers.
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Figure 72. Plot of maximum analytical signal observed for all forward powers.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
161
plasma so that regions of the plasma sampled by the mass spectrometer contain 
low concentrations of sulfur ions.
Figure 73 shows a plot of the nitrogen flow rates yielding the maximum 
background signal for all forward powers tested. A trend of increasing nitrogen flow 
rate with increasing forward power is noted in the range of 450 to 1050 W. Above 
that power, signals decrease. Figure 74 depicts background signal maxima as a 
function of applied forward power. Similar to the analytical signal trends of Figure 
72, there is a decrease in the background signal with increasing forward powers. As 
in the 31P+ study, conditions giving rise to an increase in the analytical signal 
corresponded to increases in background signals. This indicates that nitrogen 
addition is shifting the analytical ionization zone of the plasma relative to the sample 
cone. In contrast to the phosphorus experiments, the highest absolute background 
signal is found at 450 W with no nitrogen added. This indicates that the addition of 
nitrogen did not result in an absolute increase in the formation of polyatomic 
interferences. Table 20 indicates I5N 18OlH as a weakly interfering species, so a 
significant increase in the background was not expected.
Figure 75 shows a contour plot of the S/B ratio as a function of forward power 
and nitrogen flow rate. The highest S/B ratios are found at a forward power of 450 W 
with 0 and 10 mL/min nitrogen added to the nebulizer gas flow. Similar to 
phosphorus experiments, S/B ratios tend to decrease with increasing forward powers 
and nitrogen gas flow rates. It is likely that decreases in signal are due to a shifting of 
the analytical zone of the plasma and ionization quenching, as nitrogen is expected to 
lower the temperature of the central channel.
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Nitrogen Flow Rate Yielding L arg est Background Signal or 
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Figure 73. Plot of nitrogen flow rate that yields the largest background signal at all
forward powers.
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Figure 74. Plot of maximum background signal observed for all forward powers.
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Figure 75. Surface contour displaying S/B trends for sulfur against applied power 
and nitrogen flow rate added to the nebulizer gas.
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Table 23 lists the forward power and nitrogen flow rates that yield the 
lowest detection limits for sulfur. Detection limits remain in the single ppb range for 
almost all power levels. The best detection limit is obtained at a forward power of 
450 W with no additional nitrogen added to the nebulizer gas flow.
Nitrogen Study Conclusions
At lower power levels, the size and stability o f the plasma is reduced with 
increasing amounts of nitrogen. Higher power levels allow the plasma to tolerate 
higher flows of nitrogen gas. The plasma does not shrink significantly and the 
plasma demonstrates increased stability. The central channel, however, appears less 
dense. This has been observed by other groups utilizing nitrogen addition to the 
nebulizer gas flow79. The darkening of the central channel indicates plasma cooling 
as thermal energy is absorbed by the strong nitrogen covalent bonds (9.80 eV). 
Spectroscopic experiments77 and computer simulations66 support this. Cooling of the 
central channel of the plasma would increase the time required to efficiently atomize 
and ionize nonmetal atoms, negatively affecting sensitivity.
For sulfur at m/z = 34, sensitivity was depressed with the addition of nitrogen. 
This may be due to plasma cooling and chemistry changes that lead to less efficient 
sulfur ionization. Significant increases in the background ion count were not 
observed with supplemental nitrogen gas. Higher powered plasmas were more able 
to tolerate increasing flows of nitrogen. For phosphorus at m/z = 31, background 
levels tended to increase with added nitrogen. It is likely that these background
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Table 23. Table of nitrogen flow rates yielding the lowest detection limit for sulfur at
each forward power utilized.
Forward Power Detection Limit S/B Ratio Nitrogen Flow
(W) (ppb) Rate (mL/min)
450 1 28 0
550 3 16 10
650 3 12 10
750 4 15 20
850 10 9 20
950 9 9 30
1050 9 9 40
1150 11 8 20
1250 7 5 20
1350 13 4 30
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increases are due to 14N 160 ' h +. It is likely that S/B depression with the addition 
of nitrogen is due to a combination of background interferences, ionization 
suppression, and shifts in the analytical region of the plasma.
Results and Discussion for Helium Addition 
Introduction
There have been few reported studies involving helium addition to the 
nebulizer gas flow. As noted previously, Profrock and co-workers76 and Caruso and 
co-workers73 found sensitivity enhancements for several nonmetal analytes with the 
addition of 30 mL/min of helium and 5% helium added to the nebulizer gas flow, 
respectively. Sesi et al.79 performed fundamental studies of helium gas addition.
With the addition of 16.7% helium to the nebulizer gas flow, these workers found a 
decrease in the electron number density in the central region of the plasma and an 
increase in the gas kinetic temperature of 1500 K. They also observed that, in 
contrast to experiments with nitrogen, the addition of helium did not significantly 
alter the appearance, shape or density of the plasma.
The study presented in this dissertation is intended to examine trends for the 
analytical response o f  small additions o f  helium to the nebulizer gas flow , with the 
goal of improving the ionization behavior of difficult to ionize elements. Sulfur was 
the nonmetal element studied in this experiment. Nebulization and transport 
efficiency was held constant with a fixed nebulizer gas flow of 1.00 L/min. Helium
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gas was added post-sample-introduction in amounts ranging from 0-80 mL/min. 
System optimization was performed by maximizing the analytical signal for an 
aqueous solution of sulfur at a forward power of 450 W. Sampling was held constant 
and helium gas flow rates were tested at forward powers between 450-590 W in 
increments of 20 W. Mass spectral scans were obtained for blank and sulfur- 
containing solutions.
Physical Properties of an Argon ICP with Added Helium
In contrast to oxygen and nitrogen addition experiments, the addition of 
helium did not have a noticeable effect on the size, shape, and density of the plasma. 
Reflected power remained below 5 watts at all helium flow rates for all power levels. 
The lack of a visible effect on the plasma may indicate that helium is not being 
significantly ionized by the ICP. Small shifts in the analytical zone of the plasma are 
still expected as the total gas flow rate changes due to the additional helium.
Data for Helium Addition
Initial experiments involving helium gas addition were carried out under 
conditions identical to those of the nitrogen addition experiments. Forward powers 
ranged from 450-1350 W with 0-80 mL/min of helium added to the nebulizer gas. At 
powers of 650 W and greater, the analytical and background signals were not 
measurable with any helium gas flow rate except those at 70 and 80 mL/min. These
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signals were very small at 650 W and disappeared entirely when the forward 
power reached 750 W. It appeared that the signal and background trends are similar 
to that of an all-argon plasma, shown previously in Figure 33. It is likely that helium 
is not being ionized and is not affecting the macroscopic properties of the argon ICP.
In an effort to further characterize this behavior, the helium addition 
experiments were repeated at forward power levels between 450-570 W in increments 
of 20 W. Figures 76-79 show the background and analytical signals for 450,490, 550 
and 590 W and helium flow rates ranging from 0 to 80 mL/min. Figures 80-82 show 
the signal and background trends as a function of forward power at 0,10 and 30 
mL/min helium. Figures 83 and 84 show the S/B trend at a forward powers of 450 
and 550 W, respectively.
Helium Addition: Sulfur Results
Sulfur was monitored at 34S+. The analytical signal is plotted as a function of 
helium flow rate for selected power levels in Figures 76-79. The graphs show a large 
variability in trends from one power level to another. At higher powers, 550 and 590 
W, the addition of helium increased the analytical signal. At these powers, the 
analytical signal also exhibited a larger helium flow rate range in which a significant 
34S+ signal was observed. It is likely that at the lower forward powers, 450 and 490 
W, the analytical zone of the plasma, where the concentration of sulfur ions is 
highest, is in close proximity to the sample cone orifice. At low forward powers, an 
increase in the helium flow rate results in a decrease in the analytical signal. When
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Figure 76. Plot of analytical (♦) and background (■) signals at an applied forward
power of 450 watts.
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Figure 77. Plot of analytical (♦) and background (■) signals at an applied forward
power of 490 watts.
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Figure 78. Plot of analytical (♦) and background (■) signals at an applied forward
power of 550 watts.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
173





-  2000 
<0
■5 *  1000 
</)
0 20 40 60 80
Helium Flow Rate (mL/min)
Figure 79. Plot of signal analytical (♦) and background (■) signals at an applied
forward power of 590 watts.
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Signal and Background vs Forward Pow er for 
No Addition of Helium
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Figure 80. Plot of analytical (♦) and background (■) signals against applied forward 
power with no helium added to the nebulizer gas flow.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
175
Signal and Background vs Forward Power for 
10m L/m in Addition of Helium
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Figure 81. Plot of analytical (♦) and background (■) signals against applied forward 
power with 10 mL/min of helium added to the nebulizer gas flow.
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Signal and Background vs Forward Power for 30 
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Figure 82. Plot of analytical (♦) and background (■) signals against applied forward 
power with 30 mL/min of helium added to the nebulizer gas flow.
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Figure 83. Plot of S/B ratio against helium gas flow rate at an applied forward power
o f450W.
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Figure 84. Plot of S/B ratio against helium gas flow rate at an applied forward power
of 550 W.
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operated at 590 W, the plasma is more dense and the ion channel is less well 
defined. Ionization likely occurs earlier in the plasma, increasing the size of the 
analytical zone and shifting the zone of maximum ionization towards the load coil. 
Hence, at high forward powers, larger flows of helium are required to shift the 
analytical zone of the plasma towards the sample cone.
Figures 76-79 also show the background signal trends. The background signal 
intensity increases with increases in helium flows. It is unclear why this occurs. It 
has been shown that the addition of helium raises the gas kinetic temperature79 of the 
plasma. Generally, an increase in temperature yields a robust plasma, with increased 
resistance to the formation of polyatomic species. It is possible that higher helium 
flow rates shift the region of the plasma with a high concentration of background ions 
closer to the sample cone. Another potential explanation is that the plasma is actually 
“cooled” by the helium and/or the residence times of all species within the plasma is 
reduced. These conditions might contribute to increases in the molecular ion 
interferences. Table 20 indicates that the major polyatomic ion that would cause high 
backgrounds is 15N I80 1H+. Noting that the natural abundance of these elements are 
low and that helium is not an interferent, the increase in the background signals with 
increasing helium flow is unexpected. Further experimentation is necessary to 
deduce the cause for this background level increase.
As qualitatively seen in Figures 76-79, both analytical and background ion 
signals decrease significantly at higher forward powers (>600 W). These trends are 
similar to signal reductions shown for an all-argon plasma (Figure 33). This trend 
can be visualized with the helium doped argon plasma by plotting the signal and
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background as a function of applied forward power at various helium flow rates. 
Figures 80-82 show such plots at 0,10, and 30 mL/min helium. This data clearly 
shows a profile similar to that of Figure 33. Results indicate an optimal plasma 
power, and perhaps an optimal sampling region, at each helium flow rate. The graphs 
also indicate the peak signals are obtained at higher forward powers with increasing 
helium gas flow rates. It is possible that higher helium gas flows cause the volume of 
the analytical region to increase, allowing for similar ion counts to be obtained at a 
wider range of forward powers.
Figures 83 and 84 demonstrate the depressive effect helium addition has on 
the S/B ratio. This is shown for forward powers of 450 and 550 W, although all 
power levels tested show this trend. The graphs indicate that the rate of change in the 
S/B ratio is greater at the lower 450 W forward power (Figure 83) as compared to that 
at 550 W (Figure 84). This is an indication that the analytical zone of the plasma is 
either shifted less or is larger at higher forward powers.
To conclude, the addition of helium gas to the nebulizer gas flow of an 
argon ICP did not yield any benefit in the analytical sensitivity of 34S+. The helium- 
doped plasma behaved similarly to an all-argon plasma, indicating that helium in 
these amounts and operating powers is not significantly being ionized or affecting 
plasma chemistry. Fluctuations in analytical and background signals are likely due to 
shifts in the analytical zone of the plasma relative to the sample cone.
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The addition of supplemental gases to the nebulizer gas flow caused signal 
depression, in most cases, for all gases and analytes studied. This depression is most 
likely due to a combination of plasma cooling and a shift in the analytical zone of the 
plasma away from the sampler and skimmer cones. Oxygen addition mitigated the 
buildup of carbon deposits on the sampler and skimmer cones. Nitrogen addition 
depressed S/B ratios for both phosphorus and sulfur analytes, reducing sensitivity and 
degrading detection limits somewhat. Helium addition had no appreciable effect on 
either the appearance of the plasma or the analytical or background signals for sulfur. 
Signal response to changing forward power levels mirrors that of an argon plasma 
indicating that helium is not being ionized to an extent sufficient to influence 
analytical signals.
Additional experiments would include performing oxygen addition post MD 
and varying the power levels to ascertain the best conditions for both organic solvent 
pyrolysis and sensitive nonmetal determinations. Supplemental gas added to the 
auxiliary or coolant gas flows should be studied with USN-MD sample introduction 
and the low powers utilized in our laboratories.
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CHAPTER 4
APPLICATION OF ICP-MS AS A DETECTOR FOR HPLC: SELECTED 
EXAMPLES AND VOLATILITY CONSIDERATIONS
Background
A critical objective of utilizing ICP-MS detection of nonmetals is its 
successful application to the analysis of molecules that are difficult to detect with 
standard HPLC detection methods. A starting point in developing additional 
applications for harder-to-ionize molecules is to select a series of nonmetal- 
containing analytes that may be speciated by HPLC. A review of what has been 
accomplished in the literature is also necessary to help guide research initiatives.
Currently a number of industries benefit from the direct coupling of HPLC to 
ICP-MS. Examples of sensitive metal and semi-metal determinations have been 
published by a number of groups. Vanhaecke and co-workers80 speciated Cr(III) and 
Cr(IV). Pu, Hu, Jiang, and Huang81 demonstrated the speciation of Fe(II) and Fe(III). 
Other groups have performed speciation and determination of metal-containing 
compounds utilizing ICP-MS82'87.
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Determinations of nonmetals by HPLC-ICP-MS have also been 
accomplished by a number of groups. B’Hymer and Caruso88 recently published a 
thorough review of the current and past literature for the speciation and detection of 
selenium with ICP-MS. Kovacevic and co-workers89 used LC-ICP-MS to speciate 
digested cell membrane phospholipids by monitoring phosphorus. Quinones and co­
workers90 utilized ion chromatography to speciate bromate and bromide in blood 
plasma. They obtained detection limits of 5 ppb utilizing ICP-MS. Caruso and co­
workers91 utilized an octopole collision cell with helium to remove nitrogen oxide 
interferences at m/z = 31 for P . Detection limits in the sub-ppb range were 
reported for several phosphorus-containing analogues of nerve agents. Marshall et
Q9 •al. quantified with HPLC-ICP-MS the metabolic by-products of brominated 
bradykinin. Jensen and co-workers presented a paper demonstrating micro-bore 
HPLC with ICP-MS for the detection of several drug compounds. Compounds 
detected monitoring chlorine included furosemide, diclofenac, clofibric acid, and 4- 
chlorobenzoic acid. Compounds detected monitoring bromine included bromofenac, 
4-bromobenzoic acid, bromazepam, and 5-bromouracil. Compounds detected 
monitoring iodine included 5-iodouracil, 4-iodobenzoic acid, 5-iodo-6-methyluracil, 
and 5-iodo-2’-deoxyuridine. Direct injection and the use of an Aridus 
microconcentric nebulizer were compared. The direct injection nebulizer sensitivity 
was found to be independent of the analyte’s structure, but varied with the amount of 
organic solvent in the matrix. Response factors when using the Aridus 
microconcentric nebulizer were dependent on the analyte structure, but did not vary 
significantly with methanol concentrations. It was hypothesized that many of the
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analyte compounds were partially lost during desolvation in the Aridus 
nebulization system. Edler, Jakubowski, and Linscheid94 speciated and quantified 
melphalan DNA adducts by selectively detecting phosphorus. Shah and Caruso95 
recently published a comprehensive review on the status and application of 
phosphorus speciation and detection by ICP-MS.
Clearly, a large body of work has been devoted to HPLC-ICP-MS. The 
majority of this work has been for the analysis of metals, semi-metals, and easy-to- 
ionize nonmetals such as selenium and arsenic. Fewer studies have been attempted to 
detect halogens and other heteroatom species. This discussion focuses on current 
projects under way in our laboratory that will help define the utility of HPLC-USN- 
MD-ICP-MS detection of nonmetal analytes.
Outline of Current HPLC Experiments Utilizing ICP-MS Detection
Several projects involving HPLC separation and ICP-MS detection of model 
pharmaceutical compounds are ongoing in our laboratory. The compounds being 
separated include:
1. isopropyl methanesulfonate (IPMS) and methyl-methionine
2. difluorobenzyl chloride (DFBC) and a bromine-containing API
3. 2,4-difluorobenzyl bromide (2,4-DFBB) and a bromine-containing API
4. 2,6-difluorobenzyl bromide (2,6-DFBB) and a bromine-containing API
5. vitamins Bi and B 1 2 .
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The structures of 2,4-DFBB, 2,6-DFBC, vitamin Bi, and methyl- 
methionine are shown in Figure 85. The structure of vitamin B 12 is shown in Figure 
86. Several of the compounds and chromatographic conditions required for 
separation are provided by Pfizer Global Research and Development. Structures for 
DFBC and the bromine-containing API are proprietary and are not shown.
Experimental 
HPLC and ICP-MS Instrumentation
A dual pump HPLC (Dynamax Model SD-200, Rainin Instruments,Woburn, 
MA) was utilized. A six-port injector with a 5 pL sample loop (Rheodyne, Cotati, 
CA) was used for all analyte injections. A UV-VIS detector (Dynamax Model UV-C, 
Rainin Instruments,Woburn, MA) was used in series with ICP-MS detection. The 
ICP-MS was a 27 MHz Fisons (Thermo Electron) Instruments PlasmaQuad II. Ion 
signals from a Burle (Sturbridge, MA) Channeltron 4870V were acquired utilizing 
Thermo Electron PlasmaLab software (Version 1.06.007, Ionflight, Boston, MA). 
Sample introduction was accomplished with a Cetac Industries (Omaha, NE) USN. 
The nebulized aerosol was directed to a MDX-200 for additional desolvation. A 
weekly routine calibration of the instrument was performed by continuously 
nebulizing a peristaltically pumped 10 ppb solution of Li, Mg, Co, In, Pb, Ce, and U 
in 1% (v/v) nitric acid at a forward power of 1350 W. Tables 24 and 25 summarize 
the operational parameters.
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Figure 85. Structures of (a) 2,4-difluorobenzyl bromide, (b) 2,6-difluorobenzyl 
bromide, (c) vitamin Bi, and (d) methyl-methionine.
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Figure 86. Structure of vitamin B 12 where X is a C=N group.
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Table 24. Operating parameters for separation of IPMS and methyl-methionine.
HPLC and USN-MD Settings
HPLC mobile phase flow rate, mL/min 0.5
Wavelength of UV-VIS Detection, nm 204
Nebulizer gas flow rate, L/min 0.8-1.0
Nebulizer heater temperature, °C 140
Nebulizer condenser temperature, °C 3
Membrane desolvator temperature, °C 160
Membrane desolvator countercurrent flow rate, L/min 1.5
ICP-MS system
Optimal RF power, W (Daily variable) 490-550 W
Detector Burle Channeltron 4870V
Outer gas flow rate, L/min 14.0
Intermediate gas flow rate, L/min 0.8
Data acquisition parameters
Scan mode Single ion monitor
Dwell time, ms 250
Isotope monitored 34S
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Table 25. Operating parameters for the separation of DFBC and DFBB from a
bromine-containing API.
HPLC and USN-MD Settings
HPLC mobile phase flow rate, mL/min 1.0
Wavelength of UV-VIS Detection, nm 220
Nebulizer gas flow rate, L/min 0.8-1.0
Nebulizer heater temperature, °C 140
Nebulizer condenser temperature, °C 3
Membrane desolvator temperature, °C 140
Membrane desolvator countercurrent flow rate, L/min 1.5
ICP-MS system
Optimal RF power, W (Daily variable) 490-550
Detector Burle Channeltron 4870V
Outer gas flow rate, L/min 14.0
Intermediate gas flow rate, L/min 0.8
Data acquisition parameters
Scan mode Single ion monitor
Dwell time, ms 250
Isotope monitored 35C1, 79Br
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Reagents and Sample Preparation
IPMS, DFBC, and the bromine-containing API were obtained from Pfizer 
Global Research and Development (PGRD, Ann Arbor, MI). 2,4-DFBB, 2,6-DFBB, 
methyl-methionine, ammonium hydroxide and formic acid were obtained from Acros 
Organics (Pittsburgh, PA). Stock solutions were made by dissolving the analytes in 
appropriate solvents. HPLC grade ACN (Fisher Scientific, Pittsburgh, PA) and 18 
MQ*cm deionized water were used as mobile phase solvents.
Chromatographic Materials and Conditions
Separations of IPMS and methyl-methionine were performed on a diol normal 
phase column (Develosil 100-5, Japan). Column dimensions were 4.6 x 100 mm and 
the stationary phase particle size was 5 pm. A mobile phase flow rate of 0.5 mL/min 
with isocratic conditions was used. The mobile phase consisted of a 20% (v/v) 
aqueous solution buffered with ammonium hydroxide and formic acid to a pH of 7 
and 80% ACN.
Separations of DFBC, 2,4-DFBB and 2,6-DFBB were accomplished on a Cig 
reverse phase column (Chromolith, Merck KGaA, Darmstadt, Germany). Column 
dimensions were 4.6 x 100 mm with 5 pm stationary phase particle size. A mobile 
phase flow rate of 1.0 mL/min with isocratic conditions was used. The mobile phase
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consisted of a 40% (v/v) aqueous solution buffered with ammonium hydroxide 
and formic acid to a pH of 7 and 60% ACN.
HPLC-ICP-MS Detection of IPMS and Methyl Methionine
HPLC-UV-VIS-ESI-MS
Figure 87 shows an HPLC-UV-VIS chromatogram of a 5 pL injection of a 
solution containing 5000 ppm IPMS and 400 ppm methyl methionine. Since IPMS 
contains poor chromophoric moieties, in-series detection by ESI-MS was necessary to 
identify the analyte peaks and retention times. Data was collected with a Bruker 
Esquire 3000 quadrupole ion trap mass spectrometer (Bruker Daltonics, Billerica, 
MA, USA). Standard electrospray conditions were utilized to obtain a sufficient ion 
signal. Figure 88 displays the data obtained from the ESI-MS detector in three 
panels. The top panel shows the total ion chromatogram. A large peak with greatest 
intensity at 13-1 .5  minutes corresponds well with the peak obtained for methyl 
methionine in the UV-VIS trace (Figure 87). The major ion peak obtained by 
continuous mass spectral scans is shown in the middle panel of Figure 88. The most 
abundant appears at m/z 164.5. This is consistent with a protonated methyl 
methionine molecule (MW =163)
A significant increase in the ion count at the expected elution time for IPMS is 
not observed in the ESI-MS total ion chromatogram (top panel Figure 88). However, 
the major ion peak observed during this time interval is 122.5 (bottom panel Figure
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Figure 87. UV-VIS trace of a mixture of 5000 ppm IPMS and 400 ppm methyl 
methionine. Methyl methionine has been assigned the peak at 7.2 min. and IPMS has
been assigned the peak at 9.7 min.
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Figure 88. HPLC-ESI-MS trace of a mixture of methyl methionine and IPMS. The 
top panel is the total ion chromatogram. The middle panel is the mass spectrum 
obtained for the methyl methionine peak. The bottom panel is the mass spectrum
obtained for the IPMS peak
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88). This ion peak corresponds to an ion of IPMS with loss of oxygen. IPMS has 
a molecular mass of 138 amu. The protonated ion peak is not observed. However,
1 ' I S  1 f tloss of oxygen (16 amu) yields IPMS -O with a molecular mass of 122 amu. For 
verification, direct injection of IPMS was performed. An identical ion peak was seen 
(Figure 89).
HPLC-UV - VIS-ICP-MS
Figure 90 shows the ICP-MS signal response to a 5 pL injection of a 25 ppt 
solution of IPMS eluted under the same conditions as in the HPLC-ESI-MS 
experiment. Sulfur was monitored as the 34S+ isotope. The chromatogram shows a 
large sulfur signal earlier in the chromatogram. This is likely an impurity in the 
IPMS sample that has a lower retention index.
Figure 91 shows the ICP-MS signal response to a 5 pL injection of a 400 ppm 
solution of methyl-methionine. The elution conditions are different than in the 
HPLC-UV-VIS-ESI-MS trace. However, this chromatogram is included to indicate 
the relative sensitivity of the ICP-MS towards methyl methionine. It is observed that 
the net analytical signal for a significantly diluted sample of methyl methionine (400 
ppm vs. 5000 ppm) is much higher than obtained for IPMS. These results indicate 
that it is likely that the high volatility of IPMS is leading to its loss in the desolvation 
elements of the sample introduction system.
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Figure 89. Mass spectrum obtained from direct injection of IPMS into the ESI-MS.
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Figure 90. HPLC-ICP-MS trace monitoring 34S+ for a 5 pL injection of a 25,000 ppm
solution of IPMS.

















Figure 91. HPLC-ICP-MS trace monitoring 34S+ for a 5 pL injection of a 400 ppm
solution of methyl methionine.
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IPMS and Methyl Methionine Conclusions
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A chromatographic method for the separation and detection of IPMS and 
methyl methionine has been demonstrated. ICP-MS results indicate a decrease in 
sensitivity for IPMS compared to methyl methionine. A mixture of IPMS and methyl 
methionine needs to be injected with the method developed with UV-VIS and ESI- 
MS detection. This will fully demonstrate the capabilities of ICP-MS as a detector 
for this analyte system. Experiments where the temperature in the sample 
introduction system is lowered and the nebulizer gas flow is increased should be 
performed. Under these conditions, the volatile IPMS will be removed less by the 
desolvating elements of the sample introduction system. This may lead to an increase 
in the sensitivity of the system to IPMS.
HPLC-USN-MD ICP-MS Analyte Volatility Concerns: DFBC, DFBB, Vitamin B i2,
and a Bromine-Containing API
Introduction
Experiments with a number of other analyte systems were accomplished in 
parallel with IPMS and methyl methionine. The results from these initial 
investigations indicate that sensitive detection of nonmetal-containing analytes is 
probably linked to the volatility of the molecule. To demonstrate this, several
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chromatograms of two binary analyte systems are presented. These analyte 
systems consisted of a bromine-containing API injected with either DFBC, 2,6- 
DFBB, or 2,4-DFBB.
Results and Discussion
Figure 92 shows the signal response of the UV detector to a 5 pL injection of 
a 1000 ppm mixture of the bromine-containing API and 2,6-DFBB. Widths at the 
baseline are approximately 30 seconds or less. Comparing this chromatogram with 
one obtained with HPLC-USN-MD-ICP-MS (Figure 93) for the same compounds at 
the same concentrations, it is observed that there is a sharp reduction in ion intensity 
for 2,6-DFBB as compared to the API.
A similar reduction in sensitivity is observed for DFBC (Figure 94). Table 26 
lists the melting points for 2,6-DFBB and DFBC. Both compounds have melting 
points well below the standard temperature settings of the MD (160 °C) and USN 
(140 °C). For comparison, the melting point of the API is in the range of 241-245 °C, 
well above the temperature settings of the MD and USN. Melting points do not 
provide a direct correlation to a compounds’ absolute volatility. However, under 
standard sample introduction conditions, 2,6-DFBB and DFBC analyte particulates 
will be present as a liquid while the API will be a solid. The vapor pressure of the
2,6-DFBB and DFBC will be much greater compared to the API. The decreased
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Figure 92. HPLC-UV-VIS trace for a 5 pL injection of a 1000 ppm mixture of the 
bromine-containing API and 2,6-DFBB.
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Figure 93. HPLC-ICP-MS trace monitoring 79Br+ for a 5 pL injection of a 1000 ppm 
mixture of the bromine-containing API and 1 ppt 2,6-DFBB.


























Figure 94. HPLC-ICP-MS trace of 5 pL injection of a 1000 ppm mixture of the 
bromine-containing API and DFBC. The blue trace corresponds to the 79Br+ signal. 
The red trace corresponds to the 35C1+ signal.
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sensitivity of 2,6-DFBB and DFBC, in comparison to the API, may be caused by 
the greater volatility of these compounds under MD conditions.
Table 26. Physical properties of select organohalides.
Physical Property 2,6-DFBB DFBC
Molecular Weight (g/mol) 207 02 162 67
Melting Point (°C) 52_55 34_3g
It is apparent from experiments in our laboratory that sensitive nonmetal 
detection is possible with nonvolatile compounds. It has been shown that there is a 
large detector response, relative to the volatile analytes, for a 1000 ppm solution of 
the bromine-containing API. Vitamin B 12 is also a nonvolatile compound with a 
melting point of 300 °C. Figure 95 shows an HPLC-ICP-MS chromatogram of a 5 pL 
injection of a 45 ppm phosphorus solution of vitamin B 1 2 . The phosphorus ion signal 
was monitored. There is a large detector response for this compound. Separation of 
vitamins B 12 and Bi are currently being performed in our laboratory to further 
demonstrate the utility of this technique.
Discussion of Chromatographic Figures of Merit for ICP-MS Detection
To gauge the performance of the USN-MD-ICP-MS relative to the UV-VIS 
detector, it is necessary to calculate the pertinent chromatographic figures of merit.

















108 96 752 3 410
Time (min)
Figure 95. HPLC-ICP-MS trace monitoring 31P+ for a 5 pL injection of a 45 ppm
phosphorus solution of vitamin Bn.
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The resolution and number of theoretical plates were calculated for the separation 
of 2,6-DFBB and the bromine-containing API. Additionally, peak tailing factors 
were calculated for the API and 2,4-DFBB in the ICP-MS chromatograms.
The number of theoretical plates for the UV-VIS chromatograms was 
calculated by approximating the peak as a triangle. This allowed a direct 
determination of the peak width at half height for peaks that saturate the detector. For 
ICP-MS chromatograms, a modified equation96 for the calculation of the number of 
theoretical plates was used due to the high degree of peak asymmetry observed for
2,6-DFBB.
4 1 . 7 ( - ^ - ) 2
N = ._____1!V1_ (4.1)
1.25 + —
A
where tr is the retention time, wo.i is the peak width at 10% of the peak maximum, B is 
the width of the right side of the peak, and A is the width of the left side of the peak. 
Resolution was calculated using the standard resolution equation given previously 
(Eqn. 1.6). Peak tailing factors were calculated for the API, 2,6-DFBB, and 2,4- 
DFBB as shown in Figure 9.
Table 27 shows the resolutions, tailing factors, and number of theoretical 
plates calculated from UV-VIS and ICP-MS chromatograms for 2,6-DFBB. Figures 
92 and 93 are representative UV-VIS and ICP-MS chromatograms used for these 
calculations. Figure 96 highlights the peak tailing observed with all of the volatile 
analytes in ICP-MS chromatograms.
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_______Table 27. Comparison of select HPLC figure o f merit for 2,6-DFBB.______
HPLC Figures of Merit ICP-MS Detection UV Detection
Resolution n , _
U.o Z A j
Tailing Factor ^ j













Figure 96. HPLC-ICP-MS trace monitoring 79Br+ for a 5pL injection of a 1 ppt 
solution of the bromine-containing API.
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The average number of theoretical plates calculated for 2,6-DFBB from 
ICP-MS chromatograms was 30. For UV-VIS detection, the number of theoretical 
plates was 1800. The large difference in plate counts between the ICP-MS and UV 
trace indicates significant band broadening. This is likely occurring in the sample 
introduction portion of the ICP-MS system. The average resolution calculated for 
this separation was 0.6 using the ICP-MS chromatogram. This is not sufficient to 
provide baseline resolution between two analyte peaks of equal intensity. However, it 
is observed that baseline resolution is achieved due to the low intensity of the 2,6- 
DFBB analyte peak. The resolution value, however, indicates that the 
chromatographic method should be improved to allow for complete separation, 
especially if  sensitivities can be increased for the volatile analytes. Complete 
separation is desired due to the potential for ionization interferences when analytes 
co-elute. The resolution obtained with UV-VIS detection was 2.45, more than 
adequate to achieve baseline resolution. Peak tailing was also observed for all the 
volatile analytes. Figure 96 shows a zoomed view of the 2,4-DFBB analyte peak, 
demonstrating the large degree of tailing. The average tailing factor in ICP-MS 
chromatograms for 2,6-DFBB was 4.5. There was no peak tailing observed in UV- 
VIS chromatograms. Although not tabulated, the average tailing factor observed for 
the less volatile API was 1.5 in ICP-MS chromatograms.
Although not shown, resolution and theoretical plate numbers for both UV- 
VIS and ICP-MS are similar for the separation of the bromine-containing API, 2,4- 
DFBB, and DFBC.
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The model separation systems presented in this dissertation are selected 
examples of the best results achieved to date. These examples also clearly 
demonstrate some of the challenges in utilizing HPLC-USN-MD-ICP-MS to detect 
nonmetal analytes. The results presented do not include failed separation examples, 
method development to optimize system performance, or other optimization 
procedures. Likewise, many of these experiments are ongoing and thus quantitative 
results such as linearity studies, mobile phase composition effects, and detection limit 
studies are yet to be determined. The data presented in this chapter are qualitative in 
nature and demonstrate initial results obtained in our laboratory.
Analyte peaks from ICP-MS chromatograms of the API and the model 
impurities exhibit significant broadening when compared to UV chromatograms. The 
volatile compounds show great reductions in sensitivities. The ICP-MS 
chromatographic figures of merit are not currently adequate, especially for volatile 
analytes. Much of the broadening seen with highly volatile organic impurities is 
thought to be a function of a combination of the temperature in the “J-tube” (140 °C) 
and in the membrane desolvator (160°C), and the volumes of the spray chamber, “J- 
tube,” and condenser region of the ultrasonic nebulizer (approximately 140 mL). It is 
likely that this combination creates a large dead volume. The aforementioned 
problems with the USN, coupled with the turbulence of the aerosol stream in the 
spray chamber and several 180° turns, may lead to significant mixing of the eluent 
and cause further band broadening.
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A volatility study should be performed to clearly define the range of 
analyte molecules and physical properties that lead to efficient detection of nonmetal 
heteroatoms. Also, the investigation of alternative nebulizer, spray chamber, and 
desolvating methods should be performed. It is possible that low volume nebulizers 
and spray chambers may lead to increased transport efficiencies for volatile analytes. 
This may lead to beneficial sensitivity enhancements for nonmetal-containing 
analytes in HPLC-ICP-MS applications.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS 
Overall Summary
This dissertation reports efforts to improve the analytical performance of 
USN-MD-ICP-MS as an HPLC detector for the analysis of heteroatom-containing 
pharmaceutical compounds. There were three core studies conducted in pursuit of 
this objective. First, an HPLC mobile phase and buffer study was completed.
Second, the utility of adding oxygen, nitrogen, and helium as supplemental gases to 
the nebulizer gas flow was established. Finally, several model heteroatom-containing 
compounds were speciated and detected by HPLC-USN-MD-ICP-MS.
HPLC Mobile Phase and Buffer Study Conclusions and Suggested Future Directions
The purpose of conducting this study was to determine which common HPLC 
mobile phases and buffers led to sensitive detection of heteroatoms in pharmaceutical 
compounds. Specifically, the response of the USN-MD-ICP-MS and AES to 
phosphorus as phosphomycin was determined. Ultimate detection limits in the
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hundreds of parts per billion were obtained for AES detection. Signal response as 
a function of mobile phase composition showed minimal variation. It was determined 
that HPLC solvent programming can be used with USN-MD-ICP-AES detection.
For ICP-MS, ultimate detection limits in the range of single parts per billion 
were obtained. Signal response as a function of mobile phase composition showed a 
large decrease in sensitivity when organic solvent was nebulized. The effects of 
buffers on the analytical signals were more pronounced in ICP-MS experiments. 
TBAH and HepS caused the largest signal and detection limit degradations. Isocratic 
separation conditions are suggested due to the large sensitivity decrease as the amount 
of organic solvent content is increased.
The scattered behavior of the phosphorus signal to the different mobile phase 
compositions and buffers in ICP-MS detection indicate that trends in signal and 
background behavior need to be established for each specific analyte. The 
background interferences and ionization processes will be different for a chlorine- 
containing analyte as opposed to a phosphorus-containing analyte. Additionally, a 
buffer and mobile phase study should be performed with alternative sample 
introduction methods, such as low flow, high efficiency nebulizers.
Supplemental Nebulizer Gas Addition Conclusions and Future Directions
The addition of supplemental gases to the nebulizer gas flow caused signal 
depression for nearly all analytes and gases studied. Signal depression is likely due to
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shifts in the analytical zone of the plasma and plasma cooling, leading to less 
efficient ionization.
Results for oxygen addition experiments showed signal depression for sulfur-, 
phosphorus-, and chlorine-containing analytes. Results for fluorine were scattered. 
Although signal depression was noted for most analytes and oxygen flow rates, 
detection limits generally remained low. Efficient combustion of deposited carbon 
was observed when oxygen comprised 6% of the nebulizer gas flow rate.
Addition of nitrogen to the nebulizer gas flow caused a decrease in the S/B 
ratio for both phosphorus and sulfur analytes. Background ion interferences were 
greater for phosphorus due to the formation of nitrogen-containing interferences. At 
higher forward powers, a greater range of nitrogen gas flow rates yielded measurable 
analytical and background signals.
Addition of helium did not produce any significant signal or detection limit 
enhancements. It is believed that helium did not become ionized in the argon plasma 
and did not significantly affect the analytical properties of the plasma.
Suggested future studies include supplementing the auxiliary or coolant gas 
flow with nitrogen and helium. Increasing the fraction of helium present in the 
plasma may allow it to be ionized efficiently, allowing a complete investigation into 
its utility as a supplemental gas. Also, the results presented produced trends 
consistent with an explanation that the analytical zone of the plasma shifts with 
supplemental gas addition. However, this shift can be unambiguously demonstrated 
by imaging the plasma with a hyper-spectral imaging instrument, utilized in our 
laboratory. This instrument can be used as a plasma diagnostic tool. The regions of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
213
the plasma where the maximum ion and excited state atom concentration is 
located can be visually determined with this instrument. Combining the ion counts 
obtained from the mass spectrometer with imaging data for different supplemental 
gases and flow rates will allow for a comprehensive determination of the ionization 
and excitation processes occurring in the ICP dining these experiments.
HPLC-USN-MD-ICP-MS Experiment Conclusions and Future Directions
The separations and detections of a bromine-containing API with, 2,6-DFBB, 
2,4-DFBB, and DFBC have been demonstrated. Significant band broadening and 
sensitivity degradation was noted for ICP-MS chromatograms as compared to UV- 
VIS chromatograms. This was more pronounced with 2,6-DFBB, 2,4-DFBB, and 
DFBC. It was observed that analytes with melting points below that found in the 
sample introduction system had increased tailing, reduced sensitivity, and poor 
chromatographic figures of merit. It is believed that the deterioration in sensitivity 
and chromatographic figures of merit is due to a combination of the heating elements 
within the sample introduction system and the large internal volume of the USN-MD.
Future investigations should include model analyte systems that are lower in 
volatility to unambiguously show the utility of USN-MD-ICP-MS as a detector for 
HPLC. A study on the relationship between analyte signal and peak shape with 
volatility-correlated physical properties should be performed. This will more clearly 
define which analytes can be sensitively detected with USN-MD-ICP-MS.
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The investigation of low flow nebulizers and spray chambers to alleviate 
analyte loss and band broadening should be performed. The incorporation of low 
flow nebulizers may allow the complete removal of the MD portion of the sample 
introduction system due to the lower solvent load on the plasma.
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